<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>High-risk dietary supplements: Patient evaluation and counseling</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">High-risk dietary supplements: Patient evaluation and counseling</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">High-risk dietary supplements: Patient evaluation and counseling</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Pieter Cohen, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Seres, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert G Hendrickson, MD, FACMT, FAACT</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sara Swenson, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H548110135"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Products containing vitamins, minerals, botanicals, live microorganisms, protein powders, and amino acids are marketed in the United States as dietary supplements [<a href="#rid1">1</a>]. Although these products may be referred to as nutraceuticals or food supplements outside of the United States, they will be referred to as dietary supplements or supplements in this chapter.</p><p>Some dietary supplements, including those containing individual vitamins and minerals, are essential components of evidence-based medical care. The efficacy and safety of vitamins, minerals, and certain botanical agents in adults are reviewed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5367.html" rel="external">"Overview of water-soluble vitamins"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5368.html" rel="external">"Vitamin intake and disease prevention"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4561.html" rel="external">"Lipid management with diet or dietary supplements"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/120019.html" rel="external">"Nutritional and non-medication supplements permitted for performance enhancement"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2022.html" rel="external">"Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7154.html" rel="external">"Treatment of vitamin B12 and folate deficiencies"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7148.html" rel="external">"Treatment of iron deficiency anemia in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1391.html" rel="external">"Clinical use of St. John's wort"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1389.html" rel="external">"Clinical use of echinacea"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1388.html" rel="external">"Clinical use of saw palmetto"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1387.html" rel="external">"Clinical use of ginkgo biloba"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1392.html" rel="external">"Overview of herbal medicine and dietary supplements"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3618.html" rel="external">"Hepatotoxicity due to herbal medications and dietary supplements"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7206.html" rel="external">"Nephropathy induced by aristolochic acid (AA) containing herbs"</a>.)</p><p></p><p>Although many dietary supplements lack evidence of efficacy or safety, patients may turn to these unproven supplements without seeking medical advice [<a href="#rid2">2</a>], and many use these products in combination with prescription medications [<a href="#rid3">3</a>]. Dietary supplements taken without medical advice may pose health risks.</p><p>In this chapter, we address the care of patients who use supplements that lack evidence of efficacy and may pose health risks, supplements we term “high-risk supplements.” The health risks from these supplements may be direct, due to adverse effects of the products themselves, or indirect, contributing to patients’ delaying or foregoing effective care. The use of high-risk supplements is important for clinicians to identify as it might contribute to a patient’s illness, may increase the risks of future adverse events, or may interfere with evidence-based care. The high-risk dietary supplements we review in this topic are not inclusive, and other supplements containing botanical (and other naturally derived) ingredients may also pose health risks.</p><p class="headingAnchor" id="H1889138869"><span class="h1">DEFINITION OF HIGH-RISK DIETARY SUPPLEMENTS</span><span class="headingEndMark"> — </span>We define high-risk supplements as those supplements that have the highest likelihood of containing listed ingredients or adulterants with unknown or inadequate safety data, as well as supplements that lead to a disproportionate number of adverse effects, emergency department (ED) visits, and hospitalizations.</p><p>The US Food and Drug Administration (FDA) has identified more than 1000 supplement products adulterated with pharmaceuticals, predominantly supplements marketed for weight loss, sexual enhancement, and muscle building [<a href="#rid4">4</a>]. In one surveillance study conducted by the Centers for Disease Control and Prevention (CDC) involving 63 sentinel EDs, investigators estimated that approximately 23,000 ED visits and more than 2100 hospitalizations per year in the United States can be attributed to the use of dietary supplements [<a href="#rid5">5</a>]. Supplements promoted for specific health benefits were responsible for 66 percent of supplement-related ED visits, with the most common including supplements marketed for weight loss, increased energy, and sexual enhancement (26, 10, and 3 percent, respectively). Supplements marketed for other specific health claims, including cardiovascular health, sleep, and bodybuilding, were also associated with an increased number of ED visits.</p><p class="headingAnchor" id="H3335790345"><span class="h1">REGULATION OF DIETARY SUPPLEMENTS</span><span class="headingEndMark"> — </span>In the United States, dietary supplements are regulated as a subcategory of food under the Dietary Supplement Health and Education Act of 1994 (DSHEA) [<a href="#rid1">1</a>]. Dietary supplements can be formulated with active pharmacologic ingredients and marketed with a variety of health claims [<a href="#rid6">6</a>]. Several aspects of the regulatory framework for dietary supplements increase the potential health risks for consumers.</p><p class="headingAnchor" id="H1214858372"><span class="h2">Regulatory deficiencies and challenges</span><span class="headingEndMark"> — </span>The US Food and Drug Administration (FDA) does not approve supplements prior to sale, nor does the agency test products to confirm labeling accuracy prior to marketing. Manufacturers are entrusted with ensuring the safety of supplements and the accuracy of the label [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H2377345967"><span class="h2">Untested health claims</span><span class="headingEndMark"> — </span>Traditional over-the-counter medications are pharmaceutical products that must include detailed and accurate information regarding quantity and safety on the label. Any health claims beyond those demonstrated in large clinical trials are not permitted on over-the-counter medications. By contrast, dietary supplements may be advertised as providing a wide variety of health benefits even if the product has never been tested in humans. For example, manufacturers are permitted to claim that a supplement “maintains normal glucose levels” even if evidence from human trials to support this claim are lacking [<a href="#rid6">6</a>]. </p><p>Although health claims on supplement labels must be accompanied by a disclaimer that the product has not been approved by the FDA, studies have demonstrated that disclaimers are not effective in educating consumers. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>In one study, 359 consumers were shown a variety of supplement labels; some labels included the required FDA disclaimer and some did not. The consumers exposed to both labels reported similar levels of agreement that the FDA appropriately evaluated the product claims [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study, 262 college students were randomly assigned to read two different supplement labels, one with the disclaimer and one without. The presence of the disclaimer had no effect on the college students’ perceptions of effectiveness ratings of the supplement [<a href="#rid8">8</a>].</p><p></p><p class="headingAnchor" id="H1470937985"><span class="h2">Passive surveillance</span><span class="headingEndMark"> — </span>The FDA relies upon a passive surveillance system to detect adverse events from supplements, depending upon consumers and clinicians to submit reports to <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fsafety%2Fmedwatch-fda-safety-information-and-adverse-event-reporting-program&amp;token=xvyaImDcLZQw%2FKZaoXWwxUDhBq6SPMBQbzrmFLdvw6uLInTYq0WEZZE23nYfEJdpji3bziSW87ksfkpGSKeZ%2FC4BVOKV%2FWdosDZdfOoBdep7W5s6oZowZkx4dccnetNU&amp;TOPIC_ID=126971" target="_blank">MedWatch</a> in case of adverse reactions suspected to be related to supplements [<a href="#rid9">9</a>]. However, only a small fraction of adverse event reports are submitted via MedWatch [<a href="#rid10">10</a>]. As a result, the FDA lacks timely, accurate information regarding hazardous supplements available to consumers.</p><p class="headingAnchor" id="H849687608"><span class="h2">Inadequate labeling</span><span class="headingEndMark"> — </span>Supplements can be formulated with "active" pharmacologic constituents, which can be as potent as pharmaceutical agents, but essential information, such as quantity of the active compound and known adverse effects, is not required to be listed on the label.</p><p>Manufacturers may place supplement ingredients within “propriety blends,” for which there is no requirement that the specific quantity of the ingredient is listed [<a href="#rid1">1</a>]. As an example, if yohimbe is listed as part of a “proprietary blend,” there is no requirement that the quantity of yohimbe is provided on the label.</p><p>Although the name of the botanical agent is required to be listed, the amount of active constituent/s within the botanical is not required to be listed. As an example, the ingredient “red yeast rice” is required to be listed, but the quantity of the active statin-like drug (ie, monacolin K) contained within the red yeast rice is not required [<a href="#rid11">11</a>]. Similarly, the specific strain of microorganism or quantity of colony-forming units is not required on the label of probiotic supplements, which is essential to determine the efficacy and appropriateness of the product [<a href="#rid12">12</a>].</p><p>Manufacturers are not required to include known adverse effects or known supplement-drug interactions on the label. As an example, St John’s wort has important interactions with many prescription drugs  (<a class="graphic graphic_table graphicRef76992" href="/d/graphic/76992.html" rel="external">table 1</a>) (see  <a class="medical medical_review" href="/d/html/1391.html" rel="external">"Clinical use of St. John's wort", section on 'Drug interactions'</a>), but this information is not required on St. John’s wort product labels.</p><p>In addition,<strong> </strong>dietary supplements have become a route whereby manufacturers can introduce pharmaceutical-like compounds directly to consumers without FDA review [<a href="#rid13">13</a>].<strong> </strong>Manufacturers may formulate dietary supplements using their own proprietary methods, containing highly variable and potentially elevated concentrations of active compounds. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>In one study, some red yeast rice supplements contained high levels of monacolin K (a chemical identical to prescription <a class="drug drug_general" data-topicid="9575" href="/d/drug information/9575.html" rel="external">lovastatin</a>), with some evaluated products containing much higher levels than expected [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study evaluating yohimbe supplements, products often marketed for sexual health, investigators found that some brands contained significantly greater quantities of the active ingredient than would be expected from an authentic botanical extraction, with some even higher than prescription doses [<a href="#rid14">14</a>].</p><p></p><p class="headingAnchor" id="H2358683777"><span class="h2">Untested new ingredients</span><span class="headingEndMark"> — </span>Manufacturers can also introduce new ingredients into supplements without evidence of efficacy or safety in humans [<a href="#rid15">15</a>]. Although manufacturers are expected to share evidence of safety with the FDA, there is no requirement to include clinical trial data. For example, the pharmaceutical drug vinpocetine, used to treat patients with dementia and strokes in some countries, was introduced into the United States in hundreds of supplements, bypassing the FDA drug approval process in this way [<a href="#rid16">16</a>].</p><p>More commonly, manufacturers introduce new ingredients in supplements without ever informing the FDA or providing any evidence of safety to the FDA. Loopholes in the regulations allow this; an example is a small amount of a new agent added as a minor ingredient in a sports drink, which is then considered a constituent of food, and the ingredient is marketed as a dietary supplement without notifying the FDA [<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H3207360847"><span class="h2">Compliance with regulation and enforcement</span><span class="headingEndMark"> — </span>In addition to the challenges posed by the regulatory framework, supplement safety is also affected by lack of compliance and enforcement, including ineffective enforcement actions.</p><p>The FDA inspects hundreds of supplement manufacturers each year to ensure compliance with <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fpharmaceutical-quality-resources%2Fcurrent-good-manufacturing-practice-cgmp-regulations&amp;token=Ach7JNhKnr0%2F33RoaB998ltR7c9mPiead8iSiD6hz7ft7dl%2FDvDJmrPEfdZbzxzXUGL2Gien9jl0%2BC3xgJpBhCIhcuDHKh978rFEQlFuag5K1cDJakGrKLjtQ91IeJXL&amp;TOPIC_ID=126971" target="_blank">Current Good Manufacturing Practice (CGMP) regulations</a>. In 2018, more than half of manufacturers were not in compliance with recommended manufacturing procedures, and one-quarter failed to determine the final composition of supplement products [<a href="#rid17">17</a>].</p><p>Many studies have found that supplements often do not contain the ingredient or quantity of ingredient listed on the label [<a href="#rid18">18,19</a>]. In one study evaluating 59 echinacea products, 10 percent contained no detectable echinacea, and of the 21 standardized preparations tested, only 43 percent were consistent with labelling [<a href="#rid19">19</a>]. In several instances, multivitamin preparations that contained compounds not listed on the label or toxic concentrations of listed compounds resulted in hospitalization and even death [<a href="#rid20">20-22</a>].</p><p>The FDA has identified more than 1000 dietary supplements that are adulterated with prohibited pharmaceutical drugs [<a href="#rid4">4</a>]. In addition, hundreds of other supplements brands have been found to contain experimental drugs such as 1,3-dimethylamylamine (DMAA) [<a href="#rid23">23</a>].</p><p>At times, the FDA sends warning letters to companies who have violated the law; these letters are often publicly available and contain details of dozens of products labeled as containing prohibited ingredients. The FDA also maintains a <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Ffood%2Fdietary-supplements%2Fdietary-supplement-ingredient-directory&amp;token=FjI1Phanv1OGp7uTit%2Fbjl8E%2B7i2Y60%2Ffqmq30JmPDf54ZWGaqIlXkh19jKcpJ7RY9FenxCxCgIiurznJeg02EEQu2n3eA27ZSc82nKH5Z8%3D&amp;TOPIC_ID=126971" target="_blank">Dietary Supplement Ingredient Directory</a> with links to the agency’s actions and statements for each ingredient.</p><p>Historically, when the FDA has taken action to remove supplements from the marketplace, the action has often been ineffective. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>Investigators analyzed 27 FDA-recalled supplements 2.9 years after the recall; of the products still available for sale, two-thirds were found to be adulterated with at least one pharmaceutical or experimental drug [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study, supplements were tested before and after the FDA prohibited four stimulants in supplements; all four stimulants were still present in the supplements up to four years later [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a 2022 study, 29 percent of supplements subject to previous FDA warning letters regarding prohibited stimulants were still available for sale up to seven years later, with the majority containing prohibited ingredients [<a href="#rid26">26</a>].</p><p></p><p>In some instances, the FDA has appeared to not enforce the law. In one study evaluating an FDA database, 746 brands of supplement adulterated with drugs had been identified by the agency, although recalls were issued for only 48 percent of the products [<a href="#rid27">27</a>]. The reason for the FDA's failure to recall more than half of the identified adulterated products is unknown [<a href="#rid28">28</a>]. In other instances, the FDA discovered experimental drugs in supplements but failed to inform consumers or warn manufacturers to remove the experimental drug [<a href="#rid29">29,30</a>].</p><p class="headingAnchor" id="H1950357986"><span class="h1">DETERMINING IF YOUR PATIENT IS USING A HIGH-RISK SUPPLEMENT</span></p><p class="headingAnchor" id="H4240024617"><span class="h2">Inquire about supplement use</span><span class="headingEndMark"> — </span>Clinicians may not routinely inquire about the use of supplements, and patients frequently do not fully disclose their use of supplements to their providers.</p><p class="bulletIndent1"><span class="glyph">●</span>In one study, only 26 percent of patients disclosed their use of dietary supplements to their primary care provider [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 299 hospitalized patients in Israel, 27 percent used herbal or dietary supplements, but a review of hospital charts revealed documentation of their use in only 23 percent of users [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study, 78 outpatients reported using a total of 466 supplement products but had disclosed only 156 (33 percent) to their providers [<a href="#rid33">33</a>].</p><p></p><p class="headingAnchor" id="H3982175144"><span class="h3">How to elicit an accurate supplement use history</span><span class="headingEndMark"> — </span>Although there are a lack of high-quality data on the efficacy of approaches to eliciting patients' supplement use, in our clinical experience, a supportive, nonjudgmental approach encourages open communication and increases patients’ willingness to share this information. It is of particular importance to specifically ask about supplement use when patients have symptoms and conditions for which high-risk supplements are typically marketed, such as overweight/obesity, sexual dysfunction, and memory/cognitive difficulties. We use questions such as:</p><p class="bulletIndent1"><span class="glyph">●</span>“Many of my patients are trying to [lose weight/improve sexual function/enhance memory, etc] and frequently use over-the-counter supplements to help. Have you tried any over-the-counter supplements to help with this?” [<a href="#rid34">34</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>“I’m interested in learning about the products you have tried to [control your weight/help with sexual function/improve your memory, etc] that were not prescribed by a doctor, including over-the-counter products such as pills, powders, and liquids” [<a href="#rid35">35</a>].</p><p></p><p>In patients who routinely exercise, sports supplements are likely to be one of the most commonly consumed high-risk supplements [<a href="#rid36">36</a>]. Asking all patients who exercise about the use of sports supplements in a nonjudgmental fashion is advised. A variant of the following question can be effective:</p><p class="bulletIndent1"><span class="glyph">●</span>“Many of my patients who exercise use over-the-counter protein powders and pre-workout and muscle-building supplements to help them exercise; have you tried any of these?”</p><p></p><p>When a patient reports using an over-the-counter product, it can often be difficult to determine if it is marketed as a medication, dietary supplement, or traditional food. The "facts panel" on the label should be examined: “Supplement Facts” panels are required on <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Ffood%2Fdietary-supplements-guidance-documents-regulatory-information%2Fdietary-supplement-labeling-guide-chapter-iv-nutrition-labeling%234-2&amp;token=y6JAjLCV4A5sD03V5yIiBMsGaJ%2Bb6Pr6L7iFVXQkxoKxPT%2FmTmPMbmPXgy3zZnBZj3Yk6gELByHzuJG%2B0z3VlHRFlBghbdARxcNBh8ywfLUFkGxilRDYESVUcoc2NFz1CnBTd6jMbFqffcFnDQ%2BGghGchyarg0nr1iw2ttSwrYk%3D&amp;TOPIC_ID=126971" target="_blank">labels for products sold as a dietary supplements</a>, “Drug Facts” panels on labels for products sold as over-the-counter drugs, and “Nutrition Facts” panels on labels for products sold as traditional food.</p><p>Once supplement use is established, explore further; ask why your patient is using supplements and use this information to tailor counseling. The same supplement product can be used for a variety of different purposes by different patients. For example, a patient might use a specific supplement product to lose weight, while another patient may use the same product to improve endurance or enhance mental acuity.</p><p class="headingAnchor" id="H4158789480"><span class="h3">Determining if a supplement is high-risk</span><span class="headingEndMark"> — </span>While there is no absolute way to determine if a dietary supplement contains potentially harmful ingredients, there is some guidance to help consumers determine supplement safety based upon the label  (<a class="graphic graphic_table graphicRef139391" href="/d/graphic/139391.html" rel="external">table 2</a>). In general, safer products are those with fewer ingredients; products that have certain third-party verification seals (ie, Banned Substances Control Group [BSCG] Certified Drug Free, NSF Certified for Sport, United States Pharmacopeia [USP], or Informed Sport); products with less than 200 mg of <a class="drug drug_general" data-topicid="9213" href="/d/drug information/9213.html" rel="external">caffeine</a> per serving; products with all listed ingredients &lt;200 percent of the daily value (DV); labels that are free of words such as "proprietary," "blend," "matrix," or "complex"; and products that are free of questionable health claims [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H154574511"><span class="h1">SPORTS SUPPLEMENTS</span><span class="headingEndMark"> — </span>Sports supplements are commonly used by athletes at all levels of skill and competition (see  <a class="medical medical_review" href="/d/html/120019.html" rel="external">"Nutritional and non-medication supplements permitted for performance enhancement"</a> and  <a class="medical medical_review" href="/d/html/7475.html" rel="external">"Use of androgens and other hormones by athletes"</a> and  <a class="medical medical_review" href="/d/html/15454.html" rel="external">"Prohibited non-hormonal performance-enhancing drugs in sport"</a> and  <a class="medical medical_review" href="/d/html/109127.html" rel="external">"Prescription and non-prescription medications permitted for performance enhancement"</a>). In one survey including 557 collegiate athletes, 45 percent reported using a dietary supplement on at least two of the prior seven days, and 8 percent used sports supplements considered high risk [<a href="#rid36">36</a>].</p><p>Sports supplements may be organized into three general categories to understand risk and counsel patients.</p><p class="headingAnchor" id="H2524583138"><span class="h2">Protein, amino acids, creatine, and similar supplements (lower risk)</span><span class="headingEndMark"> — </span>Some sports supplements contain only protein powder, creatine, beta-alanine, amino acids or carnitine, and some athletes use these products to increase the amount of protein or protein precursors in their diet. The efficacy and safety profiles of these ingredients vary, and consumers using these sports supplements containing these individual ingredients may be counseled based on the potential benefits and risks of the ingredients; this is reviewed in detail elsewhere (see  <a class="medical medical_review" href="/d/html/120019.html" rel="external">"Nutritional and non-medication supplements permitted for performance enhancement"</a>). While this category is relatively low risk compared with other sports supplements, the use of these products may still pose certain risks, such as excessive protein intake in patients with kidney dysfunction [<a href="#rid38">38</a>]. Use of these supplements is common in young adults, especially males [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H2561656460"><span class="h2">Pre-workout supplements with proprietary blends (higher risk)</span><span class="headingEndMark"> — </span>Pre-workout supplements are those marketed to be used prior to exercise to improve energy, strength, or endurance. Many pre-workout supplements contain complex mixtures of ingredients, frequently listed on the label as “proprietary blends,” without quantities of individual ingredients provided  (<a class="graphic graphic_table graphicRef139130" href="/d/graphic/139130.html" rel="external">table 3</a>). There are several potential risks associated with pre-workout supplements:</p><p class="bulletIndent1"><span class="glyph">●</span>The labels of sports supplements often do not provide accurate information about the content of <a class="drug drug_general" data-topicid="9213" href="/d/drug information/9213.html" rel="external">caffeine</a> or other stimulants [<a href="#rid40">40,41</a>]. In particular, caffeine is particularly problematic for athletes and clinicians when trying to understand how much is being ingested when using pre-workout supplements. Although caffeine can provide benefits to athletes [<a href="#rid42">42</a>], unpredictable dosages may be counterproductive. (See  <a class="medical medical_review" href="/d/html/120019.html" rel="external">"Nutritional and non-medication supplements permitted for performance enhancement", section on 'Caffeine'</a>.)</p><p></p><p class="bulletIndent1">In one study evaluating 31 sports supplements, the products were analyzed for <a class="drug drug_general" data-topicid="9213" href="/d/drug information/9213.html" rel="external">caffeine</a> content and compared with the information provided on the label [<a href="#rid41">41</a>]. Twenty products listed caffeine, but less than half provided accurate amounts. There is no legal limit of amount of caffeine in dietary supplements, and further, even if caffeine is declared as part of a "proprietary blend," the specific quantity is not required to be listed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A number of experimental stimulants, including analogs of <a class="drug drug_general" data-topicid="9114" href="/d/drug information/9114.html" rel="external">ephedrine</a>, amphetamine, and methamphetamine, have been found in sports supplements [<a href="#rid29">29,43,44</a>]. Consuming these agents may lead to increases in blood pressure and cardiac demand, potentially leading to complications such as hemorrhagic stroke and sudden death [<a href="#rid45">45-47</a>].</p><p></p><p class="headingAnchor" id="H777919504"><span class="h2">Anabolic (muscle-building) supplements (higher risk)</span><span class="headingEndMark"> — </span>Supplements marketed as natural testosterone replacements may list proprietary blends or a single ingredient on the label. However, analyses of these products have found anabolic steroids and a wide range of steroid-like compounds with a variety of anabolic and other endocrine effects and may include agents such as selective androgen receptor modulators (SARMs), selective estrogen receptor modulators (SERMs), and aromatase inhibitors  (<a class="graphic graphic_table graphicRef139138" href="/d/graphic/139138.html" rel="external">table 4</a>) [<a href="#rid48">48-52</a>]. These products may pose a variety of significant health risks such as gynecomastia, lipid abnormalities, hypogonadism, hallucinations, cholestasis, peliosis hepatis, and hepatocellular injury, which may be severe [<a href="#rid51">51,53-56</a>]. In 2023, the US Food and Drug Administration (FDA) issued a consumer warning that they continue to receive reports of SARM-related adverse events [<a href="#rid57">57</a>]. (See  <a class="medical medical_review" href="/d/html/3618.html" rel="external">"Hepatotoxicity due to herbal medications and dietary supplements", section on 'Anabolic (muscle-building) supplements'</a> and  <a class="medical medical_review" href="/d/html/7475.html" rel="external">"Use of androgens and other hormones by athletes", section on 'Side effects and complications'</a>.)</p><p>In one study of muscle-building supplements, none of the products evaluated was accurately labeled; less than half of labeled ingredients were present, and less than one-third of listed quantities were accurate [<a href="#rid48">48</a>]. Further, ingredients detected included those with potential anabolic effects (7-keto dehydroepiandrosterone and ecdysterone), an unapproved drug with abuse potential (phenibut), and a designer steroid that may function as an aromatase inhibitor (arimistane). No ingredients carried an FDA-approved indication.</p><p class="headingAnchor" id="H740676596"><span class="h2">Counseling patients who use sports supplements</span><span class="headingEndMark"> — </span>For patients who elect to use sports supplements, we provide the following information and advice:</p><p class="bulletIndent1"><span class="glyph">●</span>We emphasize that eating a healthy well-balanced diet is more important than consuming supplements, and there are several ways for an athlete to improve their diet. Excellent <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.usada.org%2Fathletes%2Fsubstances%2Fnutrition%2F&amp;token=lFzHfu5Xyr2WkFJhkf9tPz8gEchWjjNls1yC6M5FO2X%2B3DQZrTFbLBpMQjOxa1T3OLwUII6LUNOpWPrYW3SlxA%3D%3D&amp;TOPIC_ID=126971" target="_blank">nutritional resources</a> for athletes are available from the US Anti-Doping Agency (USADA) as well as from other organizations.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a patient strongly desires to take a sports supplement, we advise choosing products that list well-studied ingredients, such as protein powder, amino acids, or creatine, and avoid pre-workout and muscle-building supplements. When selecting sports supplements, patient should use products which have been evaluated by a high-quality third party such as NSF International for Sport [<a href="#rid58">58</a>]. Before consuming any supplement product, the patient should check the ingredient with the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.usada.org%2Fathletes%2Fsubstances%2Fsupplement-connect%2F&amp;token=ACJ2ppTOcav02krMqpuO3nO%2BZX0xW8pvBLFnuUhCW%2BBDxYYpS2ZkbYDimOfPuz7sJxOtGutnZbp6TWJjKdAqeA%3D%3D&amp;TOPIC_ID=126971" target="_blank">USADA</a> high-risk list as well as the Department of Defense’s <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.opss.org%2F&amp;token=mJ2XuLqdLLe0%2BA8rZisyxrtd5Tc4U8fK4DmOg5R7dGc%3D&amp;TOPIC_ID=126971" target="_blank">Operation Supplement Safety program</a>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a patient chooses to use <a class="drug drug_general" data-topicid="9213" href="/d/drug information/9213.html" rel="external">caffeine</a> to enhance exercise performance, the best-studied dose is 100 to 200 mg (see  <a class="medical medical_review" href="/d/html/120019.html" rel="external">"Nutritional and non-medication supplements permitted for performance enhancement", section on 'Caffeine'</a>). This can be accurately dosed using over-the-counter caffeine tablets instead of consuming dietary supplements (the latter of which may contain unpredictable quantities of caffeine combined with other stimulants). Use of caffeine is not advised for children or adolescents.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>To learn more about safety of supplements, athletes should be directed to the USADA <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.usada.org%2Fathletes%2Fsubstances%2Fsupplement-connect%2F&amp;token=ACJ2ppTOcav02krMqpuO3nO%2BZX0xW8pvBLFnuUhCW%2BBDxYYpS2ZkbYDimOfPuz7sJxOtGutnZbp6TWJjKdAqeA%3D%3D&amp;TOPIC_ID=126971" target="_blank">Supplement Connect program</a>, including their guide to reducing supplement risk [<a href="#rid59">59</a>].</p><p></p><p class="headingAnchor" id="H768121917"><span class="h1">WEIGHT LOSS SUPPLEMENTS</span><span class="headingEndMark"> — </span>Weight loss supplements are commonly used by adults in the United States. In one cross-sectional telephone survey including over 9400 adults, 15 percent of respondents reported having ever used a weight loss supplement (20 percent of females and 10 percent of males), and the majority of users reported not having discussed this with their health care provider [<a href="#rid35">35</a>]. Use of weight loss supplements may be even higher among certain groups. As an example, in another survey of 1444 adults, 34 percent of those who had made a serious weight loss attempt reported the use of weight loss supplements [<a href="#rid60">60</a>]. Despite the high prevalence of use, there is no high-quality evidence that any ingredient sold as a dietary supplement can lead to safe, long-term weight loss. (See  <a class="medical medical_review" href="/d/html/5376.html" rel="external">"Obesity in adults: Drug therapy", section on 'Therapies not recommended'</a>.)</p><p>In the 1990s, ephedra was the most common ingredient in weight loss supplements. Ephedra was eventually linked to thousands of adverse effects, including myocardial infarction and sudden death [<a href="#rid61">61</a>]. The US Food and Drug Administration (FDA) banned ephedra alkaloids from supplements in 2004, and since then, ephedra has been replaced with experimental stimulants in weight loss supplements  (<a class="graphic graphic_table graphicRef139130" href="/d/graphic/139130.html" rel="external">table 3</a>) [<a href="#rid62">62</a>]. These include synthetic variants of <a class="drug drug_general" data-topicid="9114" href="/d/drug information/9114.html" rel="external">ephedrine</a>, amphetamine, and methamphetamine [<a href="#rid29">29,43,44</a>]. One example is 1,3-dimethylamylamine (DMAA), originally marketed in the 1940s as an over-the-counter nasal inhaler, but DMAA was withdrawn from the market by the 1970s [<a href="#rid23">23,63,64</a>]. DMAA began to appear in supplements shortly after ephedra was banned, and became available in hundreds of brands of supplements until the FDA prohibited its sale in 2008 due to potential health risks including heart disease and sudden death [<a href="#rid65">65</a>]. DMAA continues to be available in supplements despite the FDA’s prohibition [<a href="#rid30">30,66</a>].</p><p>The health risks of these stimulants are poorly understood. These agents may increase blood pressure, heart rate, and cardiac output. Case reports have linked these stimulants to hemorrhagic stroke and sudden cardiac death [<a href="#rid45">45,46,64,67,68</a>]. As these supplements may contain complex mixtures of chemicals never tested together in humans, they may also lead to unexpected adverse effects: a hepatitis outbreak following the use of a weight loss/workout supplement affected 69 consumers, of whom 32 were hospitalized, three required liver transplants, and two died [<a href="#rid53">53,69,70</a>]. (See  <a class="medical medical_review" href="/d/html/3618.html" rel="external">"Hepatotoxicity due to herbal medications and dietary supplements", section on 'Weight-loss products'</a>.)</p><p>In addition to novel and experimental stimulants, withdrawn prescription pharmaceutical agents are commonly found as adulterants in weight loss supplements  (<a class="graphic graphic_table graphicRef139130" href="/d/graphic/139130.html" rel="external">table 3</a>) [<a href="#rid71">71,72</a>]. The most commonly detected adulterant is sibutramine [<a href="#rid27">27</a>], a drug that was previously available by prescription [<a href="#rid73">73,74</a>] until evidence demonstrated that it increased the risk of nonfatal stroke and myocardial infarction among those at increased risk for cardiovascular disease [<a href="#rid75">75</a>]. The FDA has identified hundreds of weight loss supplement products that contain sibutramine, often in combination with the withdrawn laxative phenolphthalein. Some of these products contain greater-than-prescription-strength quantities of sibutramine, and dry mouth, anxiety, and insomnia have been reported as common side effects [<a href="#rid76">76</a>].</p><p>2,4-dintrophenol is an industrial chemical used as a raw material for explosives. The agent uncouples mitochondrial oxidative phosphorylation, with the energy that would have been stored in the cell released as heat. Initially used in the 1930s as a potent weight loss medication, it was banned by the FDA within a decade due to a variety of significant toxicities including agranulocytosis, neuropathy, hearing loss, and associated fatalities [<a href="#rid77">77</a>]. Since the 1980s, 2,4-dintrophenol has been sporadically identified as the cause of death among teenagers and young adults using the drug to lose weight [<a href="#rid78">78-80</a>]. Since 2011, the use of the 2,4-dintrophenol has increased globally [<a href="#rid81">81</a>], with products containing the agent typically sold illicitly, often on the "dark web"; in 2015, Interpol issued a global ‘imminent threat’ advisory [<a href="#rid82">82</a>]. In a 2021 study including 204 cases of 2,4-dintrophenol exposures, confusion/agitation, tachycardia, hyperpyrexia, and acidosis at presentation were associated with higher mortality rates [<a href="#rid83">83</a>].</p><p>There are occasional reports of cardiac glycoside toxicity from adulteration of supplements with yellow oleander or from mistaking yellow oleander seeds for candlenut seeds (<em>Aleurites moluccana</em>, “Nuez de la India”), which have been used as weight loss supplements [<a href="#rid84">84,85</a>]. Between 2020 and 2022, supplements labeled as tejocote root (<em>Crataegus mexicana, </em>Mexican hawthorn, “Alipotec”) were found to contain yellow oleander instead of tejocote [<a href="#rid85">85,86</a>]. Yellow oleander toxicity is similar to <a class="drug drug_general" data-topicid="9360" href="/d/drug information/9360.html" rel="external">digoxin</a> toxicity and includes nausea, vomiting, bradycardia, hypotension, frequent premature ventricular complexes, heart blocks, hyperkalemia, and ventricular dysrhythmias and/or asystole in severe cases. Symptomatic patients warrant treatment with digoxin-specific antibody (Fab) fragments. (See  <a class="medical medical_review" href="/d/html/16521.html" rel="external">"Toxic plant ingestions in children: Management", section on 'Cardiac glycosides'</a> and  <a class="medical medical_review" href="/d/html/319.html" rel="external">"Digitalis (cardiac glycoside) poisoning"</a> and  <a class="medical medical_review" href="/d/html/944.html" rel="external">"Cardiac arrhythmias due to digoxin toxicity"</a>.)</p><p class="headingAnchor" id="H1859773127"><span class="h2">Counseling patients who use weight loss supplements</span><span class="headingEndMark"> — </span>Although the FDA advises consumers to avoid any supplement with unrealistic weight loss claim such as “guaranteed weight loss” [<a href="#rid87">87</a>], we recommend that patients not use <strong>any</strong> weight loss dietary supplements since none are proven safe or effective for weight loss. However, counseling patients regarding this can be challenging. Our approach with patients who use weight loss supplements includes:</p><p class="bulletIndent1"><span class="glyph">●</span>When a patient shares with us that they are using, or considering using a weight loss supplement, we use this as an opportunity to counsel the patient on healthy weight loss strategies and engage them in evidence-based weight management approaches. (See  <a class="medical medical_review" href="/d/html/5371.html" rel="external">"Obesity in adults: Overview of management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a patient is unwilling to consider discontinuing weight loss supplements, we counsel against the use of supplements listing many ingredients in a “proprietary blend,” which can pose serious health risks and may be adulterated with unapproved drugs. Instead, patients should use a product listing a single ingredient. Selecting an ingredient based on a reliable source such as the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fods.od.nih.gov%2Ffactsheets%2FWeightLoss-Consumer%2F&amp;token=2%2BVUdM5u3ipFY2ffOQIu0kMVD4ImnhO2hKDhIhHICEpt86X8girwv92AmggJ%2Fj3s0pNTBTvv3cMHyTqRLpSs4Q%3D%3D&amp;TOPIC_ID=126971" target="_blank">National Institute of Health fact sheet on dietary supplements for weight loss</a> can be helpful.</p><p></p><p class="headingAnchor" id="H780917113"><span class="h1">MALE SEXUAL ENHANCEMENT SUPPLEMENTS</span><span class="headingEndMark"> — </span>Many dietary supplements products are sold with the claim that they will improve male sexual function; however, we are unaware of any supplement with proven benefits for sexual dysfunction [<a href="#rid88">88</a>]. Some consumers may try these supplements rather than seek medical advice because it is more convenient than seeing a clinician, or they might be embarrassed discussing their concerns. Other consumers may have contraindications to phosphodiesterase-5 (PDE-5) inhibitors  (<a class="graphic graphic_table graphicRef80719" href="/d/graphic/80719.html" rel="external">table 5</a>) and turn to these supplements after they have been counseled by their provider to avoid prescription erectile dysfunction medications.</p><p>The prevalence of use of male sexual enhancement supplements in the United States is unknown, although indirect evidence that their use is common; a single manufacturer in the United States produced more than one million capsules per month of adulterated male sexual enhancement supplements [<a href="#rid88">88,89</a>]. In fact, the US Food and Drug Administration (FDA) has identified hundreds of brands of sexual enhancement products adulterated with prescription and experimental drugs [<a href="#rid4">4,90</a>].</p><p>Of the botanical ingredients commonly found in male sexual enhancement supplements, yohimbe is one of the most likely to cause adverse effects  (<a class="graphic graphic_table graphicRef139129" href="/d/graphic/139129.html" rel="external">table 6</a>). The most active compound in yohimbe is yohimbine, which was formerly available as a prescription drug for erectile dysfunction. Yohimbine may increase blood pressure and cause panic attacks [<a href="#rid14">14</a>]. Some male sexual enhancement products are formulated with larger-than-pharmaceutical quantities of yohimbine, increasing the risks of adverse events [<a href="#rid14">14,91</a>].</p><p>In addition to botanical ingredients, pharmaceutical adulterants are also found in sexual enhancement supplements, most frequently the prescription PDE-5 inhibitors <a class="drug drug_general" data-topicid="9643" href="/d/drug information/9643.html" rel="external">sildenafil</a> and <a class="drug drug_general" data-topicid="10108" href="/d/drug information/10108.html" rel="external">tadalafil</a>, as well as novel analogues of these prescription drugs  (<a class="graphic graphic_table graphicRef139129" href="/d/graphic/139129.html" rel="external">table 6</a>). More than 80 different analogues of PDE-5 inhibitors have been identified in sexual enhancement supplements [<a href="#rid92">92</a>]. Many products have been found to contain multiple PDE-5 analogues (eg, dithiodesmethylcarbodenafil) [<a href="#rid93">93-95</a>]. In 2022, the FDA issued a warning that honey-based products (eg, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fmedication-health-fraud%2Fpublic-notification-honeymoon-exclusive-men-women-contains-hidden-drug-ingredients&amp;token=XP06bSWUYVrX1%2Butay%2Ba0GnRWnS12NY0YdfhWNXrsiv4hiFrr8eLGIojogElvqIB4V1TXsnIfNZ0X6WKuoliRChn8Ya5Q33NirU6JZsYtdev5mUD47q5wC8pppUC2Wt5y6DTuUprdr6YKgKe15VHcA%3D%3D&amp;TOPIC_ID=126971" target="_blank">"Honeymoon"</a>) promoted for sexual enhancement by various internet retailers contained PDE-5 inhibitors, such as sildenafil and tadalafil [<a href="#rid96">96</a>]. As of 2023, products containing tadalafil (eg, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fmedication-health-fraud%2Fpublic-notification-manners-energy-boost-contains-hidden-drug-ingredient&amp;token=8Qn%2B3J3VFbhCZg3zwE%2FIzONVJ4GtOnw8r2CWaTF%2B7lalr3aNAOvV6P5z6DFGbYT3pRE4DLKsvL4zr4UKbRuZAJACWu1MOREL10%2FfB8ANLqN43DQ%2FBMPgMCXt%2FlSjcZ6WlFa6aB%2B%2BKWWVBEgNNsWk8A%3D%3D&amp;TOPIC_ID=126971" target="_blank">“Manners”</a>) have been branded for “energy” and not as sexual enhancement supplements, possibly to avoid internet retailers' algorithms prohibiting their sale [<a href="#rid97">97</a>].</p><p>Adulterated male sexual enhancement supplements may pose risks to consumers. While drugs such as <a class="drug drug_general" data-topicid="9643" href="/d/drug information/9643.html" rel="external">sildenafil</a> and <a class="drug drug_general" data-topicid="10108" href="/d/drug information/10108.html" rel="external">tadalafil</a> are designed to inhibit only one family of phosphodiesterases and selectively target the penile corpus cavernosum, less selective inhibitors may affect other organ systems such as the brain, heart, kidney, and liver and have unpredictable adverse effects [<a href="#rid88">88</a>]. Sildenafil analogues have been associated with giddiness, headache, dyspnea, backache, ataxia, and one fatality [<a href="#rid98">98-100</a>]. Most of these experimental PDE-5 inhibitors in sexual enhancement supplements have not been studied in humans, and their health risks remain unknown.</p><p>Some products might contain mixtures of different experimental PDE-5 inhibitors or other prescription drugs [<a href="#rid90">90</a>]. Life-threatening hypoglycemia due to adulteration with sulfonylureas has occurred with adulterated sexual enhancement products [<a href="#rid101">101</a>]. It is not understood why prescription hyperglycemia medications are sometimes included in sexual enhancement supplements, but sulfonylureas have been found in multiple brands in the United States and elsewhere [<a href="#rid101">101-103</a>].</p><p>It is often difficult for clinicians to determine if an adulterant is present based upon a patient’s reported side effects. Common adverse effects of PDE-5 inhibitors such as flushing, lightheadedness, or dyspepsia can be identical to those of <a class="drug drug_general" data-topicid="9695" href="/d/drug information/9695.html" rel="external">niacin</a> and yohimbe, ingredients often listed on sexual enhancement supplement labels. Given the frequency of adulteration, patients experiencing any of these side effects should be counseled to immediately discontinue use of the product.</p><p class="headingAnchor" id="H3614608520"><span class="h2">Counseling patients who use sexual enhancement supplements</span><span class="headingEndMark"> — </span>Given their wide availability, all patients with sexual dysfunction should be queried if they are using, or have used, over-the-counter sexual enhancement supplement products.</p><p>We counsel patients who use sexual enhancement supplements as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>We advise patients that sexual enhancement supplements should be avoided as they are unlikely to be effective and, if they have efficacy, may be adulterated with unlabeled, untested, and potentially unsafe drugs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We also acknowledge the patient’s desire to improve their sexual function. We evaluate the patient and offer evidence-based treatment  (<a class="graphic graphic_figure graphicRef107342" href="/d/graphic/107342.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/d/html/7468.html" rel="external">"Evaluation of male sexual dysfunction"</a> and  <a class="medical medical_review" href="/d/html/7469.html" rel="external">"Treatment of male sexual dysfunction"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patient may find the FDA advisory on sexual enhancement supplements to be a useful resource [<a href="#rid104">104</a>]. Consumers and clinicians can search for specific brands of supplements in the FDA’s list of tainted sexual enhancement products [<a href="#rid105">105</a>], although if a brand is not listed on the website, it may nonetheless be adulterated but not yet identified as such.</p><p></p><p class="headingAnchor" id="H4078066412"><span class="h1">COGNITIVE ENHANCEMENT (“NOOTROPIC”) SUPPLEMENTS</span><span class="headingEndMark"> — </span>Nootropics are a broad category of agents marketed to improve cognition and memory but also include psychoactive substances that can be misused or used to self-treat withdrawal symptoms (eg, opioid withdrawal).</p><p class="headingAnchor" id="H353620923"><span class="h2">Memory enhancers</span><span class="headingEndMark"> — </span>Dietary supplements may be marketed with claims that suggest benefit for brain health or memory, such as “maintains brain health” or “maintains brain performance.”</p><p>A large market for cognitive enhancement supplements exists in the United States. Americans were estimated to spend more than USD $600 million on this category of supplements in 2015 [<a href="#rid106">106</a>], and a 2019 American Association of Retired Persons (AARP) survey found that 13 percent of adults 70 years of age or older take a supplement to treat memory loss or dementia [<a href="#rid107">107</a>].</p><p>Manufacturers may target their supplements to younger consumers interested in improving their cognitive function in the workplace or to older consumers concerned by lapses in memory due to aging or illness. Unfortunately, these supplements may be used by patients in lieu of evaluation and treatment for illnesses such as depression, strokes, and dementia.</p><p>However, no large clinical trials have provided robust, consistent evidence that dietary supplements, including botanical ingredients such as ginkgo biloba, can improve memory or cognition [<a href="#rid108">108,109</a>] (see  <a class="medical medical_review" href="/d/html/5091.html" rel="external">"Mild cognitive impairment: Prognosis and treatment", section on 'Herbs and nutritional supplements'</a>). Despite these negative results, ginkgo biloba and other botanical supplements are nonetheless permitted to be marketed to maintain cognitive health [<a href="#rid6">6</a>].</p><p>While no supplement product has been proven effective for improving cognition, cognitive enhancement supplements may pose health risks, particularly for older adults. The risks may be due to labeled ingredients, such as levodopa and vinpocetine [<a href="#rid110">110,111</a>], as well as the presence of adulterants  (<a class="graphic graphic_table graphicRef139128" href="/d/graphic/139128.html" rel="external">table 7</a>). Dozens of cognitive enhancement supplement products have been found to contain unapproved or experimental drugs; several drugs such as meclofenoxate, piracetam, and omberacetam, used in Russia and elsewhere for the treatment of several neurologic and psychiatric conditions, have been found in cognitive enhancement supplements  (<a class="graphic graphic_table graphicRef139128" href="/d/graphic/139128.html" rel="external">table 7</a>) [<a href="#rid112">112-114</a>]. These unapproved drugs have the potential to cause adverse effects including anxiety, insomnia, agitation, drowsiness, and depression.</p><p class="headingAnchor" id="H4018243280"><span class="h2">Cognitive enhancers, mood stabilizers</span><span class="headingEndMark"> — </span>These supplements include psychoactive substances that can be misused or are often used to self-treat withdrawal symptoms from other agents. Substances marketed as energy enhancers or mood stabilizers have been found to contain drugs such as kratom, tianeptine, and phenibut, with potential for dependency and overdose [<a href="#rid115">115-120</a>].</p><p>Tianeptine, an atypical tricyclic antidepressant, is used in some European, Asian, and Latin American countries to treat anxiety, depression, and irritable bowel syndrome; it is not approved for use by the US Food and Drug Administration (FDA) [<a href="#rid115">115,121</a>]. Tianeptine is a glutamate modulator and a full mu and weak delta opioid receptor agonist. In the United States, it can be purchased from internet retailers and small retail locations and thus has received the nickname "gas station heroin." It can be found in supplements claiming to provide stress relief, energy, relaxation, and as an alternative to kratom [<a href="#rid116">116</a>]. Intoxication has been reported to cause tachycardia, hypertension, lethargy, confusion, coma, and/or agitation; it can mimic opioid toxicity and has been associated with fatalities [<a href="#rid122">122-125</a>]. Tianeptine misuse can lead to rapidly escalating dosing, dependence, and with cessation, a withdrawal syndrome that mimics opioid withdrawal [<a href="#rid125">125,126</a>]. </p><p>Phenibut, which is approved for medical use in Russia and various Eastern European countries, has been found in supplements that claim to mitigate insomnia, anxiety, alcohol use disorder, and posttraumatic stress disorder. Phenibut overdose can cause sedation and respiratory depression, and chronic use can lead to tolerance and a life-threatening withdrawal syndrome with cessation. Phenibut toxicity and withdrawal are discussed separately. (See  <a class="medical medical_review" href="/d/html/141081.html" rel="external">"GABA-B agonist (baclofen, phenibut) poisoning and withdrawal"</a>.)</p><p>Kratom, an herbal agent derived from a tree native to Southeast Asia, contains alkaloids (mitragynine, 7-hydroxymitragynine) with opioid and stimulant-like properties. It is misused recreationally by adolescents and has been used for self-treatment of opioid withdrawal. Some kratom formulations contain 7-hydroxymitragynine concentrations that are greater than would be expected if derived naturally, suggesting adulteration to increase the mu-opioid effects [<a href="#rid127">127</a>]. Kratom toxicity and withdrawal are discussed separately. (See  <a class="medical medical_review" href="/d/html/7808.html" rel="external">"Opioid withdrawal: Medically supervised withdrawal during treatment for opioid use disorder", section on 'Kratom'</a>.)</p><p class="headingAnchor" id="H143172404"><span class="h2">Counseling patients who use cognitive enhancement supplements</span><span class="headingEndMark"> — </span>For all patients who have memory or cognitive concerns, we ask about the use of cognitive support or memory supplements. For patients using such supplements:</p><p class="bulletIndent1"><span class="glyph">●</span>We perform a comprehensive cognitive assessment with particular attention to screening for mood disorders and careful evaluation of sleep patterns. (See  <a class="medical medical_review" href="/d/html/5083.html" rel="external">"Evaluation of cognitive impairment and dementia"</a> and  <a class="medical medical_review" href="/d/html/14058.html" rel="external">"Mental status scales to evaluate cognition"</a> and  <a class="medical medical_review" href="/d/html/5071.html" rel="external">"Clinical features and diagnosis of Alzheimer disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We advise the avoidance of all cognitive enhancement dietary supplements; we counsel that there is no high-quality evidence that any ingredient sold as a dietary supplement can improve memory or prevent the development of dementia, and that some supplements may pose health risks. (See  <a class="medical medical_review" href="/d/html/5075.html" rel="external">"Prevention of dementia", section on 'Ineffective therapies'</a> and  <a class="medical medical_review" href="/d/html/5075.html" rel="external">"Prevention of dementia", section on 'Interventions with unproven benefit'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The safety and efficacy of ginkgo biloba for prevention of cognitive decline has been extensively studied. Although this supplement is safe, it has no effect on cognitive function. Issues pertaining to the use of ginkgo biloba are presented elsewhere. (See  <a class="medical medical_review" href="/d/html/1387.html" rel="external">"Clinical use of ginkgo biloba", section on 'Dementia, cognitive impairment, memory enhancement'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a patient elects to use dietary supplements for memory, we encourage use of single-ingredient vitamin, fish oil, or botanical products that have been certified by a high-quality third-party certification program such as <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.usp.org%2F&amp;token=lFzHfu5Xyr2WkFJhkf9tPw4Om2q7feNm0mlEdL3GywI%3D&amp;TOPIC_ID=126971" target="_blank">US Pharmacopeia</a> (USP) or <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.nsf.org%2F&amp;token=OJpa7WnHcNTDFJJhmVS3w29dsrjOzfoufCyersp4GY0%3D&amp;TOPIC_ID=126971" target="_blank">NSF International</a>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients who elect to use a single-ingredient botanical supplement, potential adverse effects can be obtained from a reputable resource such as the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fods.od.nih.gov%2Ffactsheets%2Flist-Botanicals%2F&amp;token=2%2BVUdM5u3ipFY2ffOQIu0kMVD4ImnhO2hKDhIhHICEodpdNHVGon1b4%2FbU%2F9nSi8WGD4ErVcZzrw4d%2FpUA5gWA%3D%3D&amp;TOPIC_ID=126971" target="_blank">NIH botanical supplement fact sheets</a>.</p><p></p><p class="headingAnchor" id="H814377762"><span class="h1">OTHER CATEGORIES</span><span class="headingEndMark"> — </span>Other dietary supplements may be marketed to treat or prevent many different conditions, and patients should be counseled to avoid all such supplements. For example, supplements targeting patients with cancer, diabetes, hyperlipidemia, thyroid disease, rheumatological conditions, coronavirus disease 2019 (COVID-19), and other infections are common. Although not comprehensively studied, these supplements may be more likely to be adulterated with pharmaceutically active drugs than other supplements. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>Supplements marketed for treatment of rheumatologic disorders and joint symptoms (eg, “Artri Ajo King”) have been found to contain <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a>, <a class="drug drug_general" data-topicid="9348" href="/d/drug information/9348.html" rel="external">diclofenac</a>, <a class="drug drug_general" data-topicid="8559" href="/d/drug information/8559.html" rel="external">indomethacin</a>, and <a class="drug drug_general" data-topicid="9628" href="/d/drug information/9628.html" rel="external">methocarbamol</a> [<a href="#rid128">128-135</a>]. Clinicians should inquire about the use of supplements for joint symptoms and caution against using these products, particularly if prescribing a nonsteroidal antiinflammatory, muscle relaxant, or corticosteroid, in order to prevent adverse effects from accidental supratherapeutic dosing. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Supplements marketed for "adrenal support" or "thyroid support" have been found to contain thyroid hormone and a variety of steroid hormones [<a href="#rid136">136</a>].</p><p></p><p>Clinicians should counsel patients regarding the possible presence of active, potentially harmful drugs in these products while addressing the patient’s underlying concerns and medical issues.</p><p class="headingAnchor" id="H3631719942"><span class="h1">IF YOU SUSPECT A DIETARY SUPPLEMENT HAS HARMED YOUR PATIENT</span><span class="headingEndMark"> — </span>There are several important steps to take if a clinician suspects that a patient has experienced an adverse effect from a dietary supplement. In order of importance:</p><p class="bulletIndent1"><span class="glyph">●</span>Manage the patient as clinically appropriate, including emergency department (ED) evaluation if necessary. Immediate guidance can be obtained by contacting a regional poison control center. (See <a class="local">'Regional poison control centers'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Counsel patients to immediately discontinue the product. Advise the patient about the potential connection between supplement product use and the adverse effect. We have found it helpful to explain that dietary supplements can contain compounds as potent as prescription medications but are not evaluated by the US Food and Drug Administration (FDA) before they are sold to consumers.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If appropriate, contact the local department of public health; for example, if you suspect multiple patients may have been harmed by the same product.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When possible, obtain and save the supplement product(s) in question. Store the product in a secure, cool, dry location.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Report the case to the FDA via <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fsafety%2Fmedwatch-fda-safety-information-and-adverse-event-reporting-program&amp;token=xvyaImDcLZQw%2FKZaoXWwxUDhBq6SPMBQbzrmFLdvw6uLInTYq0WEZZE23nYfEJdpji3bziSW87ksfkpGSKeZ%2FC4BVOKV%2FWdosDZdfOoBdep7W5s6oZowZkx4dccnetNU&amp;TOPIC_ID=126971" target="_blank">MedWatch</a> along with detailed product information (eg, manufacturer, name, and lot number) if available. The FDA lacks an active surveillance system and must rely upon consumers, health care providers, and others to report adverse effects to <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fsafety%2Fmedical-product-safety-information%2Fmedwatch-forms-fda-safety-reporting&amp;token=1Ak6H%2FBA0XF03s2y8Sy8SICeYBa30lmTa4mv7xSYXrHVJfvspsZ5Jd7upL4IXq5V51x%2Bt9kJ7YSHTqdAFllGCT0VPmpFBBm9Uz0i%2FhdT1y1HmtuDtUJpiB5tqZEHYFUL&amp;TOPIC_ID=126971" target="_blank">MedWatch</a>. The agency is particularly reliant on detailed reports of suspected harm submitted by clinicians. A clinician need not be convinced that the supplement led to an adverse event prior to submitting a report. Rather, the report serves as a notification to the FDA of a possible reaction related to a supplement, and the agency can monitor and assess if additional signals of harm exist.</p><p></p><p>If a clinician is interested in more detailed information about supplements in general or an individual product, we advise referencing available databases to get further information or to determine if the product has been subjected to a recall or previously found to be adulterated [<a href="#rid4">4,137</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fods.od.nih.gov%2Ffactsheets%2FExerciseAndAthleticPerformance-HealthProfessional%2F&amp;token=S801C7umjPyePqEmslhTJcUtaEzidolYgSzN89WHB3HBSJFQGsYiubVZuPGk%2BG3FZBrCfZjEmzlpU0ec%2FsqM%2BbukrOCTk1%2BCyhb6UBM0xnnVyh4yf5SoItuWboEjYEvC&amp;TOPIC_ID=126971" target="_blank">NIH: Dietary supplements for exercise and athletic performance</a></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fods.od.nih.gov%2Ffactsheets%2FWeightLoss-HealthProfessional%2F&amp;token=zCQsXtV20pR26k2WOkMaWEwMhrRti72qEkFh3uhuX7KMznBA0adfls%2BhSZFOEpBY3z9U8EgH6rqm3TVkIurois9TwNX6CDpJLhPsKc%2BycNM%3D&amp;TOPIC_ID=126971" target="_blank">NIH: Dietary supplements for weight loss</a></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmedlineplus.gov%2Fdruginformation.html&amp;token=d5ngiCbB8xFYJWkFI1xcekh7CTTcVcbY3fVxLXEvc7RXjTKgwwYaXlu2tfr5TDjDxAEjoAJ1bGlnH7fn7YS7BA%3D%3D&amp;TOPIC_ID=126971" target="_blank">MedlinePlus: Drugs, Herbs and Supplements</a></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fods.od.nih.gov%2FResearch%2FDietary_Supplement_Label_Database.aspx&amp;token=bWwQ6c9H5DDVgyuk1WAbB1ISTXLAnPT3aCOV4xMBddWmDvN7u5lpmAKiXyBSSQWS%2FvlNUq8ELwfnKEfq2ExUasTQ7hgoI%2BkTFbhDxePW3Jw%3D&amp;TOPIC_ID=126971" target="_blank">Dietary Supplement Label Database</a></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fsafety%2Frecalls-market-withdrawals-safety-alerts&amp;token=%2FyIlhGEtXGvK%2FPIxEhHYRF9YGxJJNwQ4SyL7U%2FlbOalMhlv8hF0va2cYP7EUBDUgSVWuADdw3tjiUIZtFzqGDrDqJ2RTVY5bsXJV9DErBuQ%3D&amp;TOPIC_ID=126971" target="_blank">US FDA Recalls, Market Withdrawals, &amp; Safety Alerts</a></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fconsumers%2Fhealth-fraud-scams%2Fhealth-fraud-product-database&amp;token=UN%2Fm8b%2FcX0vSFWm3lmIPjgT5mkYugpx6uQKoSVIwVhMt0%2FZnHEhUnaHB9Hi%2BJ8rW9su7EKbpcPNd2%2FdEkdYB2BR5lqSVFcz3QGPSjm%2F7FUQ%3D&amp;TOPIC_ID=126971" target="_blank">US FDA Health Fraud Product Database</a></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwebgate.ec.europa.eu%2Frasff-window%2Fscreen%2Fsearch&amp;token=7J8dMlwDfelfHNYgF%2FZqR8Kq04MHWI3I42oACR5nxuOXBH4WE0MkrYOpAd7Drpu%2B%2FxBnudjKhc20m20%2F5uaQpg%3D%3D&amp;TOPIC_ID=126971" target="_blank">European Rapid Alert System for Food and Feed (RASSF)</a></p><p></p><p class="headingAnchor" id="H2490433855"><span class="h1">ADDITIONAL RESOURCES</span></p><p class="headingAnchor" id="H657657466"><span class="h2">Regional poison control centers</span><span class="headingEndMark"> — </span>Regional poison control centers in the United States are available at all times for consultation on patients with known or suspected poisoning, and who may be critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have medical toxicologists available for bedside consultation. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for poison centers around the world is provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/138307.html" rel="external">"Society guideline links: Regional poison control centers"</a>.)</p><p class="headingAnchor" id="H1233964655"><span class="h2">Society guideline links</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/132308.html" rel="external">"Society guideline links: Performance-enhancing substances"</a> and  <a class="medical medical_society_guidelines" href="/d/html/112689.html" rel="external">"Society guideline links: General measures for acute poisoning treatment"</a> and  <a class="medical medical_society_guidelines" href="/d/html/114014.html" rel="external">"Society guideline links: Treatment of acute poisoning caused by specific agents other than drugs of abuse"</a>.)</p><p class="headingAnchor" id="H107245292"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>What is a "high-risk" dietary supplement?</strong> – We define high-risk supplements as those supplements that have the highest likelihood of containing listed ingredients or adulterants with unknown or inadequate safety data, as well as supplements that lead to a disproportionate number of adverse effects, emergency department (ED) visits, and hospitalizations. (See <a class="local">'Introduction'</a> above and <a class="local">'Definition of high-risk dietary supplements'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Regulatory issues with dietary supplements</strong> – The US Food and Drug Administration (FDA) does not approve supplements prior to sale, nor does the agency test products to confirm labeling accuracy prior to marketing. Dietary supplements may be advertised as providing a wide variety of health benefits even if the product has never been tested in humans. Supplements can be formulated with active pharmacologic constituents which can be as potent as pharmaceutical agents, but information such as quantity of the active compound and known adverse effects are not required to be listed on the label. Manufacturers may place supplement ingredients within “propriety blends,” for which there is no requirement that the specific quantity of the ingredient is listed. In addition to these challenges, supplement safety is also affected by ineffective enforcement actions. (See <a class="local">'Regulation of dietary supplements'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Importance of asking about supplement use</strong> – Clinicians may not routinely inquire about the use of supplements, and patients frequently do not fully disclose their use. A supportive, nonjudgmental approach encourages open communication and increases patients’ willingness to share this information. It is important to specifically ask about supplement use when patients have symptoms and conditions for which high-risk supplements are typically marketed, such as overweight/obesity, sexual dysfunction, and memory/cognitive difficulties.</p><p></p><p class="bulletIndent1">Once supplement use is established, explore further; ask why your patient is using the supplement and use this information to tailor counseling. (See <a class="local">'Determining if your patient is using a high-risk supplement'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sports supplements</strong> – Sports supplements may be organized into three general categories to understand risk and counsel patients: Supplements containing only protein powder, creatine, beta-alanine, amino acid or carnitine (lower risk); pre-workout supplements, typically marketed to improve energy, strength, or endurance (higher risk)  (<a class="graphic graphic_table graphicRef139130" href="/d/graphic/139130.html" rel="external">table 3</a>); and anabolic (muscle-building) supplements (higher risk)  (<a class="graphic graphic_table graphicRef139138" href="/d/graphic/139138.html" rel="external">table 4</a>). (See <a class="local">'Sports supplements'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patient counseling – For patients who use sports supplements, we emphasize that eating a healthy, well-balanced diet is more important than supplements. We recommend against using pre-workout or muscle building supplements (<a class="grade" href="https://medilib.ir/uptodate/show/grade_3" rel="external">Grade 1C</a>). If a patient strongly desires to take a sports supplement, we advise them to choose products that list well-studied ingredients, such as protein powder, amino acids, or creatine. We direct athletes to the US Anti-Doping Agency (USADA) <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.usada.org%2Fathletes%2Fsubstances%2Fsupplement-connect%2F&amp;token=ACJ2ppTOcav02krMqpuO3nO%2BZX0xW8pvBLFnuUhCW%2BBDxYYpS2ZkbYDimOfPuz7sJxOtGutnZbp6TWJjKdAqeA%3D%3D&amp;TOPIC_ID=126971" target="_blank">Supplement Connect program</a> to learn more about safety of sports supplements. (See <a class="local">'Counseling patients who use sports supplements'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Weight loss supplements</strong> – Weight loss supplements may contain experimental stimulants (including synthetic variants of <a class="drug drug_general" data-topicid="9114" href="/d/drug information/9114.html" rel="external">ephedrine</a>, amphetamine, and methamphetamine), as well as withdrawn pharmaceutical agents such as sibutramine and phenolphthalein  (<a class="graphic graphic_table graphicRef139130" href="/d/graphic/139130.html" rel="external">table 3</a>). (See <a class="local">'Weight loss supplements'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patient counseling – We recommend against all weight loss dietary supplements (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). None are proven effective for weight loss, and these supplements often contain ingredients that increase the risk of cardiovascular events. We also use this as an opportunity to counsel the patient on healthy weight loss strategies and engage them in evidence-based weight management approaches. (See <a class="local">'Counseling patients who use weight loss supplements'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Male sexual enhancement supplements</strong> – Some consumers may try these supplements rather than seek medical advice because of convenience or embarrassment. Others may have contraindications to phosphodiesterase-5 (PDE-5) inhibitors  (<a class="graphic graphic_table graphicRef80719" href="/d/graphic/80719.html" rel="external">table 5</a>) and turn to supplements after they have been counseled to avoid these medications. Yohimbe (of which the most active compound is yohimbine) and pharmaceutical adulterants are commonly found in sexual enhancement supplements, most frequently the prescription PDE-5 inhibitors <a class="drug drug_general" data-topicid="9643" href="/d/drug information/9643.html" rel="external">sildenafil</a> and <a class="drug drug_general" data-topicid="10108" href="/d/drug information/10108.html" rel="external">tadalafil</a>, as well as novel analogues of these drugs  (<a class="graphic graphic_table graphicRef139129" href="/d/graphic/139129.html" rel="external">table 6</a>). (See <a class="local">'Male sexual enhancement supplements'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patient counseling – We suggest not using sexual enhancement supplements (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>), since these supplements generally lack efficacy and have potential harm. We acknowledge the patient’s desire to improve sexual function and offer evidence-based treatment for male sexual dysfunction  (<a class="graphic graphic_figure graphicRef107342" href="/d/graphic/107342.html" rel="external">figure 1</a>). (See <a class="local">'Counseling patients who use sexual enhancement supplements'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cognitive enhancement ("nootropic") supplements</strong> – No supplement product has been proven effective for improving cognition, and dozens of cognitive enhancement supplement products have been found to contain unapproved or experimental drugs  (<a class="graphic graphic_table graphicRef139128" href="/d/graphic/139128.html" rel="external">table 7</a>). (See <a class="local">'Cognitive enhancement (“nootropic”) supplements'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patient counseling – For all patients who have memory or cognitive concerns, we ask about the use of cognitive support or memory supplements. We perform a comprehensive cognitive assessment with particular attention to screening for mood disorders and careful evaluation of sleep patterns.</p><p></p><p class="bulletIndent2">The safety and efficacy of ginkgo biloba for prevention of cognitive decline has been extensively studied. Although this supplement is safe, it has no effect on cognitive function. Issues pertaining to the use of ginkgo biloba are presented elsewhere. (See  <a class="medical medical_review" href="/d/html/1387.html" rel="external">"Clinical use of ginkgo biloba", section on 'Dementia, cognitive impairment, memory enhancement'</a>.)</p><p></p><p class="bulletIndent2">Other (non-ginkgo) cognitive enhancement/mood-stabilizing dietary supplements (eg, phenibut, tianeptine, kratom) may cause harm or dependence, may be misused or used to self-treat withdrawal symptoms, and should generally be avoided. These agents are discussed separately. (See  <a class="medical medical_review" href="/d/html/5075.html" rel="external">"Prevention of dementia", section on 'Interventions with unproven benefit'</a> and  <a class="medical medical_review" href="/d/html/5075.html" rel="external">"Prevention of dementia", section on 'Ineffective therapies'</a> and  <a class="medical medical_review" href="/d/html/7808.html" rel="external">"Opioid withdrawal: Medically supervised withdrawal during treatment for opioid use disorder", section on 'Kratom'</a> and  <a class="medical medical_review" href="/d/html/141081.html" rel="external">"GABA-B agonist (baclofen, phenibut) poisoning and withdrawal"</a> and <a class="local">'Counseling patients who use cognitive enhancement supplements'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>If you suspect a supplement has caused harm</strong> (see <a class="local">'If you suspect a dietary supplement has harmed your patient'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Manage the patient as clinically appropriate, including ED evaluation or poison control center consultation as necessary. (See <a class="local">'Regional poison control centers'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Advise the patient of your concern and counsel them to immediately discontinue the product. Obtain, save, and store any unused supplement product if possible.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Contact the local health department if you suspect multiple individuals may have been harmed by the product</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Report the case to the FDA via <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fsafety%2Fmedwatch-fda-safety-information-and-adverse-event-reporting-program&amp;token=xvyaImDcLZQw%2FKZaoXWwxUDhBq6SPMBQbzrmFLdvw6uLInTYq0WEZZE23nYfEJdpji3bziSW87ksfkpGSKeZ%2FC4BVOKV%2FWdosDZdfOoBdep7W5s6oZowZkx4dccnetNU&amp;TOPIC_ID=126971" target="_blank">MedWatch</a> along with detailed product information (eg, manufacturer, name, and lot number) if available. A clinician need not be convinced that the supplement led to an adverse event; the report serves as a notification to the FDA of a possible reaction related to a supplement, and the agency can monitor and assess if additional signals of harm exist. The FDA lacks an active surveillance system and must rely upon consumers, health care providers, and others to report adverse effects to <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fsafety%2Fmedical-product-safety-information%2Fmedwatch-forms-fda-safety-reporting&amp;token=1Ak6H%2FBA0XF03s2y8Sy8SICeYBa30lmTa4mv7xSYXrHVJfvspsZ5Jd7upL4IXq5V51x%2Bt9kJ7YSHTqdAFllGCT0VPmpFBBm9Uz0i%2FhdT1y1HmtuDtUJpiB5tqZEHYFUL&amp;TOPIC_ID=126971" target="_blank">MedWatch</a>.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">103rd Congress. Dietary Supplement Health and Education Act of 1994. Public Law 103-417. Available at: https://www.congress.gov/bill/103rd-congress/senate-bill/784/text (Accessed on June 08, 2021).</li><li><a class="nounderline abstract_t">Bailey RL, Gahche JJ, Miller PE, et al. Why US adults use dietary supplements. JAMA Intern Med 2013; 173:355.</a></li><li><a class="nounderline abstract_t">Agbabiaka TB, Wider B, Watson LK, Goodman C. Concurrent Use of Prescription Drugs and Herbal Medicinal Products in Older Adults: A Systematic Review. Drugs Aging 2017; 34:891.</a></li><li class="breakAll">US Food and Drug Administration. Tainted products marketed as dietary supplements. Available at: https://www.accessdata.fda.gov/scripts/sda/sdnavigation.cfm?sd=tainted_supplements_cder (Accessed on June 08, 2021).</li><li><a class="nounderline abstract_t">Geller AI, Shehab N, Weidle NJ, et al. Emergency Department Visits for Adverse Events Related to Dietary Supplements. N Engl J Med 2015; 373:1531.</a></li><li><a class="nounderline abstract_t">Cohen PA. The Supplement Paradox: Negligible Benefits, Robust Consumption. JAMA 2016; 316:1453.</a></li><li><a class="nounderline abstract_t">France KR, Bone PF. Policy makers’ paradigms and evidence from consumer interpretations of dietary supplement labels. J Consum Aff 2005; 39:27.</a></li><li><a class="nounderline abstract_t">Dodge T, Kaufman A. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval. Health Psychol 2007; 26:513.</a></li><li><a class="nounderline abstract_t">Cohen PA. Hazards of hindsight--monitoring the safety of nutritional supplements. N Engl J Med 2014; 370:1277.</a></li><li><a class="nounderline abstract_t">Cohen PA. American roulette--contaminated dietary supplements. N Engl J Med 2009; 361:1523.</a></li><li><a class="nounderline abstract_t">Cohen PA, Avula B, Khan IA. Variability in strength of red yeast rice supplements purchased from mainstream retailers. Eur J Prev Cardiol 2017; 24:1431.</a></li><li><a class="nounderline abstract_t">Cohen PA. Probiotic Safety-No Guarantees. JAMA Intern Med 2018; 178:1577.</a></li><li><a class="nounderline abstract_t">Cohen PA, Bass S. Injecting Safety into Supplements - Modernizing the Dietary Supplement Law. N Engl J Med 2019; 381:2387.</a></li><li><a class="nounderline abstract_t">Cohen PA, Wang YH, Maller G, et al. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal 2016; 8:357.</a></li><li><a class="nounderline abstract_t">Cohen PA. Assessing supplement safety--the FDA's controversial proposal. N Engl J Med 2012; 366:389.</a></li><li><a class="nounderline abstract_t">Cohen PA. Vinpocetine: An Unapproved Drug Sold as a Dietary Supplement. Mayo Clin Proc 2015; 90:1455.</a></li><li><a class="nounderline abstract_t">Long J. FDA still finding same cGMP deficiencies at dietary supplement facilities. Insid Law 2018.</a></li><li><a class="nounderline abstract_t">Gordon RY, Cooperman T, Obermeyer W, Becker DJ. Marked variability of monacolin levels in commercial red yeast rice products: buyer beware! Arch Intern Med 2010; 170:1722.</a></li><li><a class="nounderline abstract_t">Gilroy CM, Steiner JF, Byers T, et al. Echinacea and truth in labeling. Arch Intern Med 2003; 163:699.</a></li><li><a class="nounderline abstract_t">MacFarquhar JK, Broussard DL, Melstrom P, et al. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med 2010; 170:256.</a></li><li><a class="nounderline abstract_t">Tran BN, Okoniewski R, Spink BC, et al. Androgenic steroids in Over-the-Counter dietary Supplements: Analysis for association with adverse health effects. Steroids 2023; 193:109199.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Epi investigation finds steroid-laced vitamins and minerals; Purity First offers product recalls. https://www.cdc.gov/nceh/hsb/success_stories/steroid_laced.htm (Accessed on August 29, 2023).</li><li><a class="nounderline abstract_t">Cohen PA. DMAA as a dietary supplement ingredient. Arch Intern Med 2012; 172:1038.</a></li><li><a class="nounderline abstract_t">Cohen PA, Maller G, DeSouza R, Neal-Kababick J. Presence of banned drugs in dietary supplements following FDA recalls. JAMA 2014; 312:1691.</a></li><li><a class="nounderline abstract_t">Cohen PA, Wen A, Gerona R. Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug Administration. JAMA Intern Med 2018; 178:1721.</a></li><li><a class="nounderline abstract_t">Cohen PA, Avula B, Katragunta K, Khan I. Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters. JAMA 2022; 328:393.</a></li><li><a class="nounderline abstract_t">Tucker J, Fischer T, Upjohn L, et al. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. JAMA Netw Open 2018; 1:e183337.</a></li><li><a class="nounderline abstract_t">Cohen PA. The FDA and Adulterated Supplements-Dereliction of Duty. JAMA Netw Open 2018; 1:e183329.</a></li><li><a class="nounderline abstract_t">Cohen PA, Bloszies C, Yee C, Gerona R. An amphetamine isomer whose efficacy and safety in humans has never been studied, β-methylphenylethylamine (BMPEA), is found in multiple dietary supplements. Drug Test Anal 2016; 8:328.</a></li><li><a class="nounderline abstract_t">Cohen PA, Travis JC, Vanhee C, et al. Nine prohibited stimulants found in sports and weight loss supplements: deterenol, phenpromethamine (Vonedrine), oxilofrine, octodrine, beta-methylphenylethylamine (BMPEA), 1,3-dimethylamylamine (1,3-DMAA), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylbutylamine (1,3-DMBA) and higenamine. Clin Toxicol (Phila) 2021; 59:975.</a></li><li><a class="nounderline abstract_t">Tarn DM, Karlamangla A, Coulter ID, et al. A cross-sectional study of provider and patient characteristics associated with outpatient disclosures of dietary supplement use. Patient Educ Couns 2015; 98:830.</a></li><li><a class="nounderline abstract_t">Goldstein LH, Elias M, Ron-Avraham G, et al. Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards. Br J Clin Pharmacol 2007; 64:373.</a></li><li><a class="nounderline abstract_t">Guzman JR, Paterniti DA, Liu Y, Tarn DM. Factors Related to Disclosure and Nondisclosure of Dietary Supplements in Primary Care, Integrative Medicine, and Naturopathic Medicine. J Fam Med Dis Prev 2019; 5.</a></li><li><a class="nounderline abstract_t">Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997; 127:61.</a></li><li><a class="nounderline abstract_t">Blanck HM, Serdula MK, Gillespie C, et al. Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc 2007; 107:441.</a></li><li><a class="nounderline abstract_t">Sassone J, Muster M, Barrack MT. Prevalence and Predictors of Higher-Risk Supplement Use Among Collegiate Athletes. J Strength Cond Res 2019; 33:443.</a></li><li class="breakAll">Department of Defense Dietary Supplement Resource. Screen your Supplement. https://www.opss.org/screen-your-supplement-safety-read-label-your-supplement-and-answer-these-questions (Accessed on August 15, 2022).</li><li><a class="nounderline abstract_t">Vasconcelos QDJS, Bachur TPR, Aragão GF. Whey protein supplementation and its potentially adverse effects on health: a systematic review. Appl Physiol Nutr Metab 2021; 46:27.</a></li><li><a class="nounderline abstract_t">Ganson KT, Nagata JM. Prevalence and correlates of appearance- and performance-enhancing drugs and substances use among a national sample of college students aged 18-30. J Am Coll Health 2022; :1.</a></li><li><a class="nounderline abstract_t">Desbrow B, Hall S, O'Connor H, et al. Caffeine content of pre-workout supplements commonly used by Australian consumers. Drug Test Anal 2019; 11:523.</a></li><li><a class="nounderline abstract_t">Cohen PA, Attipoe S, Travis J, et al. Caffeine content of dietary supplements consumed on military bases. JAMA Intern Med 2013; 173:592.</a></li><li><a class="nounderline abstract_t">Grgic J, Grgic I, Pickering C, et al. Wake up and smell the coffee: caffeine supplementation and exercise performance-an umbrella review of 21 published meta-analyses. Br J Sports Med 2020; 54:681.</a></li><li><a class="nounderline abstract_t">Cohen PA, Avula B, Venhuis B, et al. Pharmaceutical doses of the banned stimulant oxilofrine found in dietary supplements sold in the USA. Drug Test Anal 2017; 9:135.</a></li><li><a class="nounderline abstract_t">Cohen PA, Travis JC, Venhuis BJ. A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Test Anal 2014; 6:805.</a></li><li><a class="nounderline abstract_t">Cohen PA, Zeijlon R, Nardin R, et al. Hemorrhagic Stroke Probably Caused by Exercise Combined With a Sports Supplement Containing β-Methylphenylethylamine (BMPEA): A Case Report. Ann Intern Med 2015.</a></li><li><a class="nounderline abstract_t">Archer JR, Dargan PI, Lostia AM, et al. Running an unknown risk: a marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Drug Test Anal 2015; 7:433.</a></li><li><a class="nounderline abstract_t">Harris BF, Winn C, Ableman TB. Hemorrhagic Stroke in a Young Healthy Male Following Use of Pre-Workout Supplement Animal Rage XL. Mil Med 2017; 182:e2030.</a></li><li><a class="nounderline abstract_t">Cohen PA, Sharfstein J, Kamugisha A, Vanhee C. Analysis of Ingredients of Supplements in the National Institutes of Health Supplement Database Marketed as Containing a Novel Alternative to Anabolic Steroids. JAMA Netw Open 2020; 3:e202818.</a></li><li><a class="nounderline abstract_t">Van Poucke C, Detavernier C, Van Cauwenberghe R, Van Peteghem C. Determination of anabolic steroids in dietary supplements by liquid chromatography-tandem mass spectrometry. Anal Chim Acta 2007; 586:35.</a></li><li class="breakAll">US Food and Drug Administration. Warning letter: Elite Supplement Center LLC and Elite Training Facility LLC. Available at: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/elite-supplement-center-llc-and-elite-training-facility-llc-627498-07062022 (Accessed on July 14, 2022).</li><li><a class="nounderline abstract_t">Mohideen H, Hussain H, Dahiya DS, Wehbe H. Selective Androgen Receptor Modulators: An Emerging Liver Toxin. J Clin Transl Hepatol 2023; 11:188.</a></li><li><a class="nounderline abstract_t">Van Wagoner RM, Eichner A, Bhasin S, et al. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet. JAMA 2017; 318:2004.</a></li><li><a class="nounderline abstract_t">Chatham-Stephens K, Taylor E, Chang A, et al. Hepatotoxicity associated with weight loss or sports dietary supplements, including OxyELITE Pro™ - United States, 2013. Drug Test Anal 2017; 9:68.</a></li><li><a class="nounderline abstract_t">Timcheh-Hariri A, Balali-Mood M, Aryan E, et al. Toxic hepatitis in a group of 20 male body-builders taking dietary supplements. Food Chem Toxicol 2012; 50:3826.</a></li><li><a class="nounderline abstract_t">Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett 2005; 158:167.</a></li><li><a class="nounderline abstract_t">Krishnan PV, Feng ZZ, Gordon SC. Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements. J Clin Gastroenterol 2009; 43:672.</a></li><li class="breakAll">FDA Warns of Use of Selective Androgen Receptor Modulators (SARMs) Among Teens, Young Adults https://www.fda.gov/consumers/consumer-updates/fda-warns-use-selective-androgen-receptor-modulators-sarms-among-teens-young-adults (Accessed on May 02, 2023).</li><li class="breakAll">US Anti-Doping Agency. How to reduce your risk from supplements. Available at: https://www.usada.org/spirit-of-sport/how-to-reduce-your-risk-from-supplements/ (Accessed on June 08, 2021).</li><li class="breakAll">US Anti-Doping Agency. Supplement guide: Reducing supplement risk. Available at: https://www.usada.org/wp-content/uploads/supplement-guide.pdf (Accessed on June 08, 2021).</li><li><a class="nounderline abstract_t">Pillitteri JL, Shiffman S, Rohay JM, et al. Use of dietary supplements for weight loss in the United States: results of a national survey. Obesity (Silver Spring) 2008; 16:790.</a></li><li><a class="nounderline abstract_t">Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343:1833.</a></li><li><a class="nounderline abstract_t">Rasmussen N, Keizers PH. History full circle: 'Novel' sympathomimetics in supplements. Drug Test Anal 2016; 8:283.</a></li><li><a class="nounderline abstract_t">Venhuis BJ, de Kaste D. Scientific opinion on the regulatory status of 1,3-Dimethylamylamine (DMAA). Eur J Nutr Food Saf 2012; 2:93.</a></li><li><a class="nounderline abstract_t">Eliason MJ, Eichner A, Cancio A, et al. Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA). Mil Med 2012; 177:1455.</a></li><li class="breakAll">US Food and Drug Administration. DMAA in products marketed as dietary supplements. Available at: https://www.fda.gov/food/dietary-supplement-products-ingredients/dmaa-products-marketed-dietary-supplements (Accessed on June 08, 2021).</li><li><a class="nounderline abstract_t">Cohen PA, Travis JC, Keizers PHJ, et al. Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA). Clin Toxicol (Phila) 2018; 56:421.</a></li><li><a class="nounderline abstract_t">Young C, Oladipo O, Frasier S, et al. Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d. Mil Med 2012; 177:1450.</a></li><li><a class="nounderline abstract_t">Venhuis B, Keizers P, van Riel A, de Kaste D. A cocktail of synthetic stimulants found in a dietary supplement associated with serious adverse events. Drug Test Anal 2014; 6:578.</a></li><li><a class="nounderline abstract_t">Johnston DI, Chang A, Viray M, et al. Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ - Hawaii, 2013. Drug Test Anal 2016; 8:319.</a></li><li><a class="nounderline abstract_t">Roytman MM, Pörzgen P, Lee CL, et al. Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am J Gastroenterol 2014; 109:1296.</a></li><li><a class="nounderline abstract_t">Jairoun AA, Al-Hemyari SS, Shahwan M, Zyoud SH. Adulteration of Weight Loss Supplements by the Illegal Addition of Synthetic Pharmaceuticals. Molecules 2021; 26.</a></li><li><a class="nounderline abstract_t">Koncz D, Tóth B, Roza O, Csupor D. A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss. Front Pharmacol 2020; 11:611361.</a></li><li class="breakAll">US Food and Drug Administration. FDA drug safety communication: FDA recommends against the continued use of Meridia (sibutramine). October 2010. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-recommends-against-continued-use-meridia-sibutramine (Accessed on May 26, 2022).</li><li class="breakAll">European Medicines Agency recommends suspension of marketing authorisation for sibutramine https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-suspension-marketing-authorisation-sibutramine (Accessed on May 26, 2022).</li><li><a class="nounderline abstract_t">James WP, Caterson ID, Coutinho W, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010; 363:905.</a></li><li><a class="nounderline abstract_t">Cohen PA, Benner C, McCormick D. Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States. J Gen Intern Med 2012; 27:51.</a></li><li class="breakAll">Swann, JP. Reducing with dinitrophenol: Self-medication and the challenge of regulating a dangerous pharmaceutical before the US Food, Drug, and Cosmetic Act. In: Perspectives on Twentieth-Century Pharmaceuticals, Viviane Quirke, Judy Slinn (Eds), Oxford, 2009.</li><li><a class="nounderline abstract_t">Hsiao AL, Santucci KA, Seo-Mayer P, et al. Pediatric fatality following ingestion of dinitrophenol: postmortem identification of a "dietary supplement". Clin Toxicol (Phila) 2005; 43:281.</a></li><li><a class="nounderline abstract_t">Miranda EJ, McIntyre IM, Parker DR, et al. Two deaths attributed to the use of 2,4-dinitrophenol. J Anal Toxicol 2006; 30:219.</a></li><li><a class="nounderline abstract_t">McFee RB, Caraccio TR, McGuigan MA, et al. Dying to be thin: a dinitrophenol related fatality. Vet Hum Toxicol 2004; 46:251.</a></li><li><a class="nounderline abstract_t">Gziut T, Thomas SHL. International trends in systemic human exposures to 2,4 dinitrophenol reported to poisons centres. Clin Toxicol (Phila) 2022; 60:628.</a></li><li class="breakAll">INTERPOL. INTERPOL issues global alert for potentially lethal illicit diet drug. May 2015. Available at: https://www.interpol.int/en/News-and-Events/News/2015/INTERPOL-issues-global-alert-for-potentially-lethal-illicit-diet-drug (Accessed on July 29, 2022).</li><li><a class="nounderline abstract_t">Potts AJ, Bowman NJ, Seger DL, Thomas SHL. Toxicoepidemiology and predictors of death in 2,4-dinitrophenol (DNP) toxicity. Clin Toxicol (Phila) 2021; 59:515.</a></li><li><a class="nounderline abstract_t">Corcoran J, Gray T, Bangh SA, et al. Fatal Yellow Oleander Poisoning Masquerading as Benign Candlenut Ingestion Taken for Weight Loss. J Emerg Med 2020; 59:e209.</a></li><li><a class="nounderline abstract_t">Berland N, Kababick J, Santos C, Calello DP. Notes from the Field: Online Weight Loss Supplements Labeled as Tejocote (Crataegus mexicana) Root, Substituted with Yellow Oleander (Cascabela thevetia) - United States, 2022. MMWR Morb Mortal Wkly Rep 2023; 72:1016.</a></li><li><a class="nounderline abstract_t">Shin D, Kang HS, Park EM, et al. Authentication of tejocote (Crataegus mexicana) dietary supplements based on DNA barcoding and chemical profiling. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2021; 38:1985.</a></li><li class="breakAll">US Food and Drug Administration. Consumer updates: Beware of products promising miracle weight loss. Available at: https://www.fda.gov/consumers/consumer-updates/beware-products-promising-miracle-weight-loss (Accessed on June 08, 2021).</li><li><a class="nounderline abstract_t">Cohen PA, Venhuis BJ. Adulterated sexual enhancement supplements: more than mojo. JAMA Intern Med 2013; 173:1169.</a></li><li class="breakAll">Canham M. Feds plow new ground in spiked supplement case. The Salt Lake Tribune, October 1, 2011. Available at: https://archive.sltrib.com/article.php?id=52657684&amp;itype=CMSID (Accessed on June 08, 2021).</li><li><a class="nounderline abstract_t">Fischer T, Tucker J, Li C, et al. Cross-Sectional Survey of Adulterated Sexual Enhancement Products Sold in the Sacramento Area of California. Nutrition and Dietary Supplements 2023; 15:111.</a></li><li><a class="nounderline abstract_t">Zanolari B, Ndjoko K, Ioset JR, et al. Qualitative and quantitative determination of yohimbine in authentic yohimbe bark and in commercial aphrodisiacs by HPLC-UV-API/ MS methods. Phytochem Anal 2003; 14:193.</a></li><li><a class="nounderline abstract_t">Kee CL, Ge X, Gilard V, et al. A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements. J Pharm Biomed Anal 2018; 147:250.</a></li><li><a class="nounderline abstract_t">Lee JH, Min AY, Park OR, et al. Detection of 94 compounds related to sexual enhancement including sildenafil, tadalafil, vardenafil and their analogues in various formulations of dietary supplements and food samples using HPLC and LC-MS/MS. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2021; 38:769.</a></li><li><a class="nounderline abstract_t">Balayssac S, Danoun S, Gilard V, et al. The POWER saga from 2007 to 2022: An example of a sexual enhancement dietary supplement tainted by different adulterants and still on the market. J Pharm Biomed Anal 2023; 227:115283.</a></li><li><a class="nounderline abstract_t">Li C, Wang X, Wu S, et al. Separation and structural elucidation of a novel vardenafil analogue as an adulterant in a natural health care dietary supplement. Heliyon 2023; 9:e15418.</a></li><li class="breakAll">US Food and Drug Administration. Tainted Honey-based Products with Hidden Active Drug Ingredients. https://www.fda.gov/consumers/health-fraud-scams/tainted-honey-based-products-hidden-active-drug-ingredients (Accessed on May 04, 2023).</li><li class="breakAll">US Food and Drug Administration. Public Notification: MANNERS Energy Boost contains hidden drug ingredient. https://www.fda.gov/drugs/medication-health-fraud/public-notification-manners-energy-boost-contains-hidden-drug-ingredient (Accessed on May 04, 2023).</li><li class="breakAll">Singapore Health Science Authority. HSA ALERTS PUBLIC TO ADVERSE REACTIONS RELATED TO THE CONSUMPTION OF ADULTERATED HEALTH PRODUCTS, INCLUDING A FATAL CASE
. https://www.hsa.gov.sg/docs/default-source/announcements-csg/press-releases/pr-three-cases-of-adrs-relating-to-illegal-pdts_final_3oct2012.pdf (Accessed on May 04, 2023).</li><li><a class="nounderline abstract_t">Bakota EL, Kelly AT, Walterscheid JP, Phatak DR. A Case Report of Fatal Desmethyl Carbodenafil Toxicity. J Anal Toxicol 2017; 41:250.</a></li><li><a class="nounderline abstract_t">Poon WT, Lam YH, Lai CK, et al. Analogues of erectile dysfunction drugs: an under-recognised threat. Hong Kong Med J 2007; 13:359.</a></li><li><a class="nounderline abstract_t">Ross JA, Downs JW, Bazydlo LA, et al. Outbreak of Severe Hypoglycemia After Ingestion of a Male Enhancement Supplement - Virginia, August-November 2019. MMWR Morb Mortal Wkly Rep 2020; 69:740.</a></li><li><a class="nounderline abstract_t">Lim CC, Gan R, Chan CL, et al. Severe hypoglycemia associated with an illegal sexual enhancement product adulterated with glibenclamide: MR imaging findings. Radiology 2009; 250:193.</a></li><li><a class="nounderline abstract_t">Kuramoto N, Yabe D, Kurose T, Seino Y. A case of hypoglycemia due to illegitimate sexual enhancement medication. Diabetes Res Clin Pract 2015; 108:e8.</a></li><li class="breakAll">US Food and Drug Administration. FDA warns consumers to avoid certain male enhancement and weight loss products sold through Amazon, eBay and other retailers due to hidden, potentially dangerous drug ingredients. December 2020. Available at: https://www.fda.gov/news-events/press-announcements/fda-warns-consumers-avoid-certain-male-enhancement-and-weight-loss-products-sold-through-amazon-ebay (Accessed on June 08, 2021).</li><li class="breakAll">US Food and Drug Administration. Tainted sexual enhancement products. Available at: https://www.fda.gov/drugs/medication-health-fraud/tainted-sexual-enhancement-products (Accessed on June 08, 2021).</li><li class="breakAll">United States Government Accountability Office. Memory supplements: Clarifying FDA and FTC roles could strengthen oversight and enhance consumer awareness. Available at: https://www.gao.gov/assets/690/685097.pdf (Accessed on May 26, 2022).</li><li><a class="nounderline abstract_t">Mehegan L, Rainville G. Brain health and dietary supplements: Where's the evidence? AARP Res 2020.</a></li><li><a class="nounderline abstract_t">DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008; 300:2253.</a></li><li><a class="nounderline abstract_t">Snitz BE, O'Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009; 302:2663.</a></li><li><a class="nounderline abstract_t">Avula B, Chittiboyina AG, Sagi S, et al. Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States. Drug Test Anal 2016; 8:334.</a></li><li><a class="nounderline abstract_t">Cohen PA, Avula B, Katragunta K, Khan I. Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database. JAMA Neurol 2022; 79:1085.</a></li><li><a class="nounderline abstract_t">Cohen PA, Zakharevich I, Gerona R. Presence of Piracetam in Cognitive Enhancement Dietary Supplements. JAMA Intern Med 2020; 180:458.</a></li><li><a class="nounderline abstract_t">Cohen PA, Avula B, Wang YH, et al. Five Unapproved Drugs Found in Cognitive Enhancement Supplements. Neurol Clin Pract 2021; 11:e303.</a></li><li><a class="nounderline abstract_t">Cohen PA, Avula B, Khan I. The unapproved drug centrophenoxine (meclofenoxate) in cognitive enhancement dietary supplements. Clin Toxicol (Phila) 2022; 60:1156.</a></li><li><a class="nounderline abstract_t">Gupta S, Wallace R, Sloshower J. Online Sales of Unscheduled Pharmaceutical Agents: A Case Report of Tianeptine Use in the United States. J Addict Med 2017; 11:411.</a></li><li><a class="nounderline abstract_t">Seale JT, Garden EA, French JM, McDougal OM. Analysis of Tianeptine in Dietary Supplements. Nutraceuticals 2023; 3:481.</a></li><li><a class="nounderline abstract_t">Jouney EA. Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable "Dietary Supplement" With Propensities for Physical Dependence and Addiction. Curr Psychiatry Rep 2019; 21:23.</a></li><li><a class="nounderline abstract_t">Cohen PA, Ellison RR, Travis JC, et al. Quantity of phenibut in dietary supplements before and after FDA warnings. Clin Toxicol (Phila) 2022; 60:486.</a></li><li><a class="nounderline abstract_t">Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol (Phila) 2008; 46:146.</a></li><li><a class="nounderline abstract_t">Palasamudram Shekar S, Rojas EE, D'Angelo CC, et al. Legally Lethal Kratom: A Herbal Supplement with Overdose Potential. J Psychoactive Drugs 2019; 51:28.</a></li><li><a class="nounderline abstract_t">Edinoff AN, Sall S, Beckman SP, et al. Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review. Pain Ther 2023; 12:1121.</a></li><li><a class="nounderline abstract_t">Bakota EL, Samms WC, Gray TR, et al. Case Reports of Fatalities Involving Tianeptine in the United States. J Anal Toxicol 2018; 42:503.</a></li><li><a class="nounderline abstract_t">Proença P, Teixeira H, Pinheiro J, et al. Fatal intoxication with tianeptine (Stablon). Forensic Sci Int 2007; 170:200.</a></li><li><a class="nounderline abstract_t">Rushton W, Whitworth B, Brown J, et al. Characteristics of tianeptine effects reported to a poison control center: a growing threat to public health. Clin Toxicol (Phila) 2021; 59:152.</a></li><li><a class="nounderline abstract_t">El Zahran T, Schier J, Glidden E, et al. Characteristics of Tianeptine Exposures Reported to the National Poison Data System - United States, 2000-2017. MMWR Morb Mortal Wkly Rep 2018; 67:815.</a></li><li><a class="nounderline abstract_t">Lauhan R, Hsu A, Alam A, Beizai K. Tianeptine Abuse and Dependence: Case Report and Literature Review. Psychosomatics 2018; 59:547.</a></li><li><a class="nounderline abstract_t">Lydecker AG, Sharma A, McCurdy CR, et al. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine. J Med Toxicol 2016; 12:341.</a></li><li class="breakAll">US Food and Drug Administration. Questions and answers: Reumofan Plus and Reumofan Plus Premium. March 2016. Available at: https://www.fda.gov/drugs/medication-health-fraud/questions-and-answers-reumofan-plus-and-reumofan-plus-premium (Accessed on July 28, 2022).</li><li class="breakAll">US Food and Drug Administration. Nano Well-being Health Inc. issues voluntary nationwide recall of Super Arthgold due to undeclared ingredients. 2013. Available at: https://wayback.archive-it.org/7993/20170406101944/https://www.fda.gov/Safety/Recalls/ArchiveRecalls/2013/ucm394631.htm (Accessed on July 28, 2022).</li><li class="breakAll">US Food &amp; Drug Administration. Public Notification: AK Forte contains hidden drug ingredients. https://www.fda.gov/drugs/medication-health-fraud/public-notification-ak-forte-contains-hidden-drug-ingredients (Accessed on May 02, 2023).</li><li class="breakAll">US Food &amp; Drug Administration. Public Notification: Artri King contains hidden drug ingredients https://www.fda.gov/drugs/medication-health-fraud/public-notification-artri-king-contains-hidden-drug-ingredients (Accessed on May 02, 2023).</li><li class="breakAll">US Food &amp; Drug Administration.Public Notification: Ortiga Mas Ajo Rey Extra Forte contains hidden drug ingredients https://www.fda.gov/drugs/medication-health-fraud/public-notification-ortiga-mas-ajo-rey-extra-forte-contains-hidden-drug-ingredients (Accessed on May 02, 2023).</li><li class="breakAll">US Food &amp; Drug Administration. Public Notification: Artri Ajo King contains hidden drug ingredient https://www.fda.gov/drugs/medication-health-fraud/public-notification-artri-ajo-king-contains-hidden-drug-ingredient (Accessed on May 02, 2023).</li><li class="breakAll">US Food &amp; Drug Administration. Public Notification: Ortiga Contains Hidden Drug Ingredient. https://www.fda.gov/drugs/medication-health-fraud/public-notification-ortiga-contains-hidden-drug-ingredient (Accessed on May 02, 2023).</li><li class="breakAll">US Food and Drug Administration. Tainted Arthritis | Pain Products. https://www.fda.gov/drugs/medication-health-fraud/tainted-arthritis-pain-products (Accessed on October 19, 2023).</li><li><a class="nounderline abstract_t">Akturk HK, Chindris AM, Hines JM, et al. Over-the-Counter "Adrenal Support" Supplements Contain Thyroid and Steroid-Based Adrenal Hormones. Mayo Clin Proc 2018; 93:284.</a></li><li class="breakAll">US Food and Drug Administration. CFSAN Adverse Event Reporting System (CAERS). Available at: https://www.fda.gov/food/compliance-enforcement-food/cfsan-adverse-event-reporting-system-caers (Accessed on June 08, 2021).</li></ol></div><div id="topicVersionRevision">Topic 126971 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.congress.gov/bill/103rd-congress/senate-bill/784/text" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 103rd Congress. Dietary Supplement Health and Education Act of 1994. Public Law 103-417. Available at: https://www.congress.gov/bill/103rd-congress/senate-bill/784/text (Accessed on June 08, 2021).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23381623" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Why US adults use dietary supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29196903" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Concurrent Use of Prescription Drugs and Herbal Medicinal Products in Older Adults: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29196903" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Concurrent Use of Prescription Drugs and Herbal Medicinal Products in Older Adults: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26465986" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Emergency Department Visits for Adverse Events Related to Dietary Supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27727369" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The Supplement Paradox: Negligible Benefits, Robust Consumption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Policy makers’paradigms and evidence from consumer interpretations of dietary supplement labels</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17605572" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24693886" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Hazards of hindsight--monitoring the safety of nutritional supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19812394" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : American roulette--contaminated dietary supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28641460" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Variability in strength of red yeast rice supplements purchased from mainstream retailers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30242393" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Probiotic Safety-No Guarantees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31851798" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Injecting Safety into Supplements - Modernizing the Dietary Supplement Law.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26391406" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Pharmaceutical quantities of yohimbine found in dietary supplements in the USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22276780" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Assessing supplement safety--the FDA's controversial proposal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26434971" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Vinpocetine: An Unapproved Drug Sold as a Dietary Supplement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : FDA still finding same cGMP deficiencies at dietary supplement facilities</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20975018" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12639203" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Echinacea and truth in labeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20142570" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Acute selenium toxicity associated with a dietary supplement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36796473" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Androgenic steroids in Over-the-Counter dietary Supplements: Analysis for association with adverse health effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36796473" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Androgenic steroids in Over-the-Counter dietary Supplements: Analysis for association with adverse health effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22566490" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : DMAA as a dietary supplement ingredient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25335153" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Presence of banned drugs in dietary supplements following FDA recalls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30422217" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug Administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35881132" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30646238" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30646231" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The FDA and Adulterated Supplements-Dereliction of Duty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25847603" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : An amphetamine isomer whose efficacy and safety in humans has never been studied,β-methylphenylethylamine (BMPEA), is found in multiple dietary supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33755516" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Nine prohibited stimulants found in sports and weight loss supplements: deterenol, phenpromethamine (Vonedrine), oxilofrine, octodrine, beta-methylphenylethylamine (BMPEA), 1,3-dimethylamylamine (1,3-DMAA), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylbutylamine (1,3-DMBA) and higenamine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25865413" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : A cross-sectional study of provider and patient characteristics associated with outpatient disclosures of dietary supplement use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17425631" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32051918" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Factors Related to Disclosure and Nondisclosure of Dietary Supplements in Primary Care, Integrative Medicine, and Naturopathic Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9214254" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Advising patients who seek alternative medical therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17324663" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Use of nonprescription dietary supplements for weight loss is common among Americans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30531412" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Prevalence and Predictors of Higher-Risk Supplement Use Among Collegiate Athletes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30531412" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Prevalence and Predictors of Higher-Risk Supplement Use Among Collegiate Athletes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32702243" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Whey protein supplementation and its potentially adverse effects on health: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35623043" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Prevalence and correlates of appearance- and performance-enhancing drugs and substances use among a national sample of college students aged 18-30.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30196576" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Caffeine content of pre-workout supplements commonly used by Australian consumers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23303430" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Caffeine content of dietary supplements consumed on military bases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30926628" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Wake up and smell the coffee: caffeine supplementation and exercise performance-an umbrella review of 21 published meta-analyses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27062112" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Pharmaceutical doses of the banned stimulant oxilofrine found in dietary supplements sold in the USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24124092" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25962129" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Hemorrhagic Stroke Probably Caused by Exercise Combined With a Sports Supplement Containingβ-Methylphenylethylamine (BMPEA): A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25641767" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Running an unknown risk: a marathon death associated with the use of 1,3-dimethylamylamine (DMAA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28885973" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Hemorrhagic Stroke in a Young Healthy Male Following Use of Pre-Workout Supplement Animal Rage XL.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32293681" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Analysis of Ingredients of Supplements in the National Institutes of Health Supplement Database Marketed as Containing a Novel Alternative to Anabolic Steroids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17386694" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Determination of anabolic steroids in dietary supplements by liquid chromatography-tandem mass spectrometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17386694" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Determination of anabolic steroids in dietary supplements by liquid chromatography-tandem mass spectrometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36479151" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Selective Androgen Receptor Modulators: An Emerging Liver Toxin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29183075" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27367536" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Hepatotoxicity associated with weight loss or sports dietary supplements, including OxyELITE Pro™- United States, 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22809474" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Toxic hepatitis in a group of 20 male body-builders taking dietary supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16005168" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Adverse effects of anabolic steroids in athletes. A constant threat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19238093" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19238093" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19238093" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19238093" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18239570" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Use of dietary supplements for weight loss in the United States: results of a national survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11117974" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27072841" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : History full circle: 'Novel' sympathomimetics in supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Scientific opinion on the regulatory status of 1,3-Dimethylamylamine (DMAA)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23397688" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23397688" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29115866" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23397687" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Hemorrhagic stroke in young healthy male following use of sports supplement Jack3d.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24802503" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : A cocktail of synthetic stimulants found in a dietary supplement associated with serious adverse events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26538199" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Hepatotoxicity associated with the dietary supplement OxyELITE Pro™- Hawaii, 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25091255" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34833995" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Adulteration of Weight Loss Supplements by the Illegal Addition of Synthetic Pharmaceuticals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33574758" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33574758" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33574758" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20818901" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21845487" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21845487" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16035205" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Pediatric fatality following ingestion of dinitrophenol: postmortem identification of a "dietary supplement".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16803658" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Two deaths attributed to the use of 2,4-dinitrophenol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15487646" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Dying to be thin: a dinitrophenol related fatality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34812657" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : International trends in systemic human exposures to 2,4 dinitrophenol reported to poisons centres.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34812657" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : International trends in systemic human exposures to 2,4 dinitrophenol reported to poisons centres.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33021407" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Toxicoepidemiology and predictors of death in 2,4-dinitrophenol (DNP) toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32917446" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Fatal Yellow Oleander Poisoning Masquerading as Benign Candlenut Ingestion Taken for Weight Loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37708076" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Notes from the Field: Online Weight Loss Supplements Labeled as Tejocote (Crataegus mexicana) Root, Substituted with Yellow Oleander (Cascabela thevetia) - United States, 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34415825" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Authentication of tejocote (Crataegus mexicana) dietary supplements based on DNA barcoding and chemical profiling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34415825" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Authentication of tejocote (Crataegus mexicana) dietary supplements based on DNA barcoding and chemical profiling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23699734" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Adulterated sexual enhancement supplements: more than mojo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23699734" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Adulterated sexual enhancement supplements: more than mojo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Cross-Sectional Survey of Adulterated Sexual Enhancement Products Sold in the Sacramento Area of California</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12892413" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Qualitative and quantitative determination of yohimbine in authentic yohimbe bark and in commercial aphrodisiacs by HPLC-UV-API/ MS methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28903860" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33818311" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Detection of 94 compounds related to sexual enhancement including sildenafil, tadalafil, vardenafil and their analogues in various formulations of dietary supplements and food samples using HPLC and LC-MS/MS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36780864" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : The POWER saga from 2007 to 2022: An example of a sexual enhancement dietary supplement tainted by different adulterants and still on the market.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37128339" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Separation and structural elucidation of a novel vardenafil analogue as an adulterant in a natural health care dietary supplement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37128339" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Separation and structural elucidation of a novel vardenafil analogue as an adulterant in a natural health care dietary supplement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37128339" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Separation and structural elucidation of a novel vardenafil analogue as an adulterant in a natural health care dietary supplement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37128339" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Separation and structural elucidation of a novel vardenafil analogue as an adulterant in a natural health care dietary supplement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27999095" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : A Case Report of Fatal Desmethyl Carbodenafil Toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17914141" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Analogues of erectile dysfunction drugs: an under-recognised threat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32555139" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Outbreak of Severe Hypoglycemia After Ingestion of a Male Enhancement Supplement - Virginia, August-November 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19017925" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Severe hypoglycemia associated with an illegal sexual enhancement product adulterated with glibenclamide: MR imaging findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25748828" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : A case of hypoglycemia due to illegitimate sexual enhancement medication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25748828" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : A case of hypoglycemia due to illegitimate sexual enhancement medication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25748828" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : A case of hypoglycemia due to illegitimate sexual enhancement medication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25748828" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : A case of hypoglycemia due to illegitimate sexual enhancement medication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Brain health and dietary supplements: Where's the evidence?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19017911" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Ginkgo biloba for prevention of dementia: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20040554" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26426301" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35939305" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31764936" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Presence of Piracetam in Cognitive Enhancement Dietary Supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34484905" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Five Unapproved Drugs Found in Cognitive Enhancement Supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35959800" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : The unapproved drug centrophenoxine (meclofenoxate) in cognitive enhancement dietary supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28742625" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Online Sales of Unscheduled Pharmaceutical Agents: A Case Report of Tianeptine Use in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Analysis of Tianeptine in Dietary Supplements</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30852710" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable "Dietary Supplement" With Propensities for Physical Dependence and Addiction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34550038" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Quantity of phenibut in dietary supplements before and after FDA warnings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18259963" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Opioid receptors and legal highs: Salvia divinorum and Kratom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30620247" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Legally Lethal Kratom: A Herbal Supplement with Overdose Potential.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37453966" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29566235" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Case Reports of Fatalities Involving Tianeptine in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17630235" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Fatal intoxication with tianeptine (Stablon).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32552075" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Characteristics of tianeptine effects reported to a poison control center: a growing threat to public health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30070980" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Characteristics of Tianeptine Exposures Reported to the National Poison Data System - United States, 2000-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30149933" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Tianeptine Abuse and Dependence: Case Report and Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27752985" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27752985" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27752985" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27752985" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27752985" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27752985" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27752985" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27752985" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27752985" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29502560" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Over-the-Counter "Adrenal Support" Supplements Contain Thyroid and Steroid-Based Adrenal Hormones.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
